<31342D3220B0A3C8A3C7D0C0C720C1F6C6F220B3EDB9AE2D33C2F72E687770>

Similar documents
ๆญฏ1.PDF

์„œ๋ก  34 2

Abstract Background : Most hospitalized children will experience physical pain as well as psychological distress. Painful procedure can increase anxie



Journal of Educational Innovation Research 2018, Vol. 28, No. 4, pp DOI: 3 * The Effect of H

Lumbar spine

< D B4D9C3CAC1A120BCD2C7C1C6AEC4DCC5C3C6AEB7BBC1EEC0C720B3EBBEC8C0C720BDC3B7C2BAB8C1A4BFA120B4EBC7D120C0AFBFEBBCBA20C6F2B0A E687770>

( )Kjhps043.hwp

Journal of Educational Innovation Research 2017, Vol. 27, No. 3, pp DOI: : A basic research

012์ž„์ˆ˜์ง„

ร€รฅยพร–ยฟรยฐรญยฟรซ ยณยปรรถ

Journal of Educational Innovation Research 2017, Vol. 27, No. 3, pp DOI: (NCS) Method of Con

278 ๊ฒฝ์ฐฐํ•™์—ฐ๊ตฌ์ œ 12 ๊ถŒ์ œ 3 ํ˜ธ ( ํ†ต๊ถŒ์ œ 31 ํ˜ธ )

ISSN ์ œ 3 ํ˜ธ ์น˜์•ˆ์ •์ฑ…์—ฐ๊ตฌ The Journal of Police Policies ( ์ œ29๊ถŒ์ œ3ํ˜ธ ) ์น˜์•ˆ์ •์ฑ…์—ฐ๊ตฌ์†Œ POLICE SCIENCE INSTITUTE

Journal of Educational Innovation Research 2018, Vol. 28, No. 2, pp DOI: IPA * Analysis of Perc


Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: * Review of Research

1..


Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: : Researc

Journal of Educational Innovation Research 2018, Vol. 28, No. 4, pp DOI: * A Research Trend


Journal of Educational Innovation Research 2016, Vol. 26, No. 3, pp DOI: Awareness, Supports


Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: * Suggestions of Ways

์„œ๋ก 

<C7D1B1B9B1B3C0B0B0B3B9DFBFF85FC7D1B1B9B1B3C0B05F3430B1C733C8A35FC5EBC7D5BABB28C3D6C1BE292DC7A5C1F6C6F7C7D42E687770>

์•ฝ์ˆ˜ํ„ฐ2ํ˜ธ์ตœ์ข…2-์›น์šฉ

์ธ๋ฌธ์‚ฌํšŒ๊ณผํ•™๊ธฐ์ˆ ์œตํ•ฉํ•™ํšŒ

<35BFCFBCBA2E687770>

DBPIA-NURIMEDIA

16(1)-3(๊ตญ๋ฌธ)(p.40-45).fm

Rheu-suppl hwp

hwp

ๆญฏkjmh2004v13n1.PDF

untitled


A 617



Journal of Educational Innovation Research 2019, Vol. 29, No. 2, pp DOI: * The Effect of Paren

ํ•œ๊ตญ์„ฑ์ธ์—์„œ์ดˆ๊ธฐํ™ฉ๋ฐ˜๋ณ€์„ฑ์งˆํ™˜๊ณผ ์—ฐ๊ด€๋œ์œ„ํ—˜์š”์ธ์—ฐ๊ตฌ

Journal of Educational Innovation Research 2018, Vol. 28, No. 3, pp DOI: The Effect of Caree

<31362DB1E8C7FDBFF82DC0FABFB9BBEA20B5B6B8B3BFB5C8ADC0C720B1B8C0FC20B8B6C4C9C6C32E687770>

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: * A Study on the Pe

Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: (LiD) - - * Way to

139~144 ยฟร€ยฐรธยพร ร„ยง

ํ™ฉ์ง€์›…

12์ด๋ฌธ๊ทœ

ร†รทร€รฅยฝรƒยผยณ94ลก

๊น€๋ฒ”์ˆ˜


๋‹ค๋ฌธํ™” ๊ฐ€์ •์˜ ๋ถ€๋ชจ

Analyses the Contents of Points per a Game and the Difference among Weight Categories after the Revision of Greco-Roman Style Wrestling Rules Han-bong

Journal of Educational Innovation Research 2018, Vol. 28, No. 3, pp DOI: NCS : * A Study on

04์กฐ๋‚จํ›ˆ

54 ํ•œ๊ตญ๊ต์œก๋ฌธ์ œ์—ฐ๊ตฌ์ œ 27 ๊ถŒ 2 ํ˜ธ, I. 1.,,,,,,, (, 1998). 14.2% 16.2% (, ), OECD (, ) % (, )., 2, 3. 3

- ์ด ๋ฌธ์„œ๋Š” ์‚ผ์„ฑ์ „์ž์˜ ๊ธฐ์ˆ  ์ž์‚ฐ์œผ๋กœ ์Šน์ธ์ž๋งŒ์ด ์‚ฌ์šฉํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค Part Picture Description 5. R emove the memory by pushing the fixed-tap out and Remove the WLAN Antenna. 6. INS

์›์œ„๋ถ€์š”์ฒ™๊ณจ๊ด€์ ˆ์งˆํ™˜์—์„œ์˜์ดˆ์ŒํŒŒ ์œ ๋„ํ•˜์Šคํ…Œ๋กœ์ด๋“œ์ฃผ์‚ฌ์น˜๋ฃŒ์˜ํšจ๊ณผ - ํ›„ํ–ฅ์  1 ๋…„๊ฒฝ๊ณผ๊ด€์ฐฐ์—ฐ๊ตฌ - ์—ฐ์„ธ๋Œ€ํ•™๊ต๋Œ€ํ•™์› ์˜ํ•™๊ณผ ๋‚จ์ƒํ˜„

Journal of Educational Innovation Research 2017, Vol. 27, No. 1, pp DOI: * The

433๋Œ€์ง€05๋ฐ•์ฐฝ์šฉ

09รˆยซยผยฎยฟยต 5~152s

Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: * The Participant Expe

. 45 1,258 ( 601, 657; 1,111, 147). Cronbach ฮฑ=.67.95, 95.1%, Kappa.95.,,,,,,.,...,.,,,,.,,,,,.. :,, ( )

J Korean Acad Child Health Nurs Vol.18 No.3, ๋ณดํ˜ธ์ž์—๋Œ€ํ•œ๊ตฌ์กฐํ™”๋œ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ๊ฐ„ํ˜ธ์ค‘์žฌ๊ฐ€์˜์œ ์•„์˜์ •๋งฅ์ฃผ์‚ฌ์œ ์ง€์—๋ฏธ์น˜๋Š”์˜ํ–ฅ ๊น€์ง€์ˆ˜ 1 ์ด์˜๋ž€ 2

์ „๋ฆฝ์„ ์•”๋ฐœ์ƒ๋ฅ ์ถ”์ •๊ณผ๊ด€๋ จ์š”์ธ๋ถ„์„ : The Korean Cancer Prevention Study-II (KCPS-II)

:,,.,. 456, 253 ( 89, 164 ), 203 ( 44, 159 ). Cronbach ฮฑ= ,.,,..,,,.,. :,, ( )

16(2)-7(p ).fm

27 2, 17-31, , * ** ***,. K 1 2 2,.,,,.,.,.,,.,. :,,, : 2009/08/19 : 2009/09/09 : 2009/09/30 * 2007 ** *** ( :

Journal of Educational Innovation Research 2017, Vol. 27, No. 1, pp DOI: NCS : G * The Analy

ๆญฏ์ œ7๊ถŒ1ํ˜ธ(์ตœ์ข…ํŽธ์ง‘).PDF

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: : A Study on the Ac

04๊น€ํ˜ธ๊ฑธ(39~50)ok

(5์ฐจ ํŽธ์ง‘).hwp

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: A study on Characte

7 1 ( 12 ) ( 1912 ) 4. 3) ( ) 1 3 1, ) ( ), ( ),. 5) ( ) ). ( ). 6). ( ). ( ).

#รˆยฒยฟรซยผยฎ

Journal of Educational Innovation Research 2016, Vol. 26, No. 2, pp DOI: * The Mediating Eff

: 4 2. : (KSVD) 4 3. :

Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: : * Research Subject


DBPIA-NURIMEDIA

( )Kju269.hwp

Treatment and Role of Hormaonal Replaement Therapy

<31335FB1C7B0E6C7CABFDC2E687770>

,......

Journal of Educational Innovation Research 2017, Vol. 27, No. 4, pp DOI: * A Study on Teache

YI Ggodme : The Lives and Diseases of Females during the Latter Half of the Joseon Dynasty as Reconstructed with Cases in Yeoksi Manpil (Stray Notes w

09๊น€์ •์‹.PDF


04_์ด๊ทผ์›_21~27.hwp

Journal of Educational Innovation Research 2019, Vol. 29, No. 2, pp DOI: 3 * Effects of 9th

Journal of Educational Innovation Research 2016, Vol. 26, No. 3, pp.1-16 DOI: * A Study on Good School

03-ร€รŒรยฆร‡รถ

878 Yu Kim, Dongjae Kim ์ง€๋ง‰ ์šฉ๋Ÿ‰์ˆ˜์ค€๊นŒ์ง€๋„ ๋ฉˆ์ถค ๊ทœ์น™์ด ๋งŒ์กฑ๋˜์ง€ ์•Š์•„ ์‹œํ–‰์ด ์ข…๋ฃŒ๋˜์ง€ ์•Š๋Š” ๊ฒฝ์šฐ์—๋Š” MTD์˜ ์ถ”์ •์ด ๋ถˆ๊ฐ€ ๋Šฅํ•˜๋‹ค๋Š” ๋‹จ์ ์ด ์žˆ๋‹ค. ์ตœ๊ทผ ์ด SM๋ฐฉ๋ฒ•์˜ ๋‹จ์ ์„ ๋ณด์™„ํ•˜๊ธฐ ์œ„ํ•ด O Quigley ๋“ฑ (1990)์ด ์ œ์•ˆํ•œ CRM(Continu

ร€รŒรร–รˆรฑ.hwp

,,,,,,, ,, 2 3,,,,,,,,,,,,,,,, (2001) 2

๋ชฉ ์ฐจ ํšŒ์‚ฌํ˜„ํ™ฉ 1. ํšŒ์‚ฌ๊ฐœ์š” 2. ํšŒ์‚ฌ์—ฐํ˜ 3. ํšŒ์‚ฌ์—…๋ฌด์˜์—ญ/์—…๋ฌดํ˜„ํ™ฉ 4. ๋“ฑ๋ก๋ฉดํ—ˆ๋ณด์œ ํ˜„ํ™ฉ 5. ์ƒํ›ˆํ˜„ํ™ฉ 6. ๊ธฐ์ˆ ์ž๋ณด์œ ํ˜„ํ™ฉ 7. ์‹œ์Šคํ…œ๋ณด์œ ํ˜„ํ™ฉ ์ฃผ์š”๊ธฐ์ˆ ์ž๋ณ„ ์•ฝ๋ ฅ 1. ๋Œ€ํ‘œ์ด์‚ฌ 2. ์ž„์›์ง‚ ์กฐ์ง ๋ฐ ์šฉ๋„๋ณ„ ์ˆ˜ํ–‰์‹ค์  1. ์กฐ์ง 2. ์šฉ๋„๋ณ„ ์ˆ˜ํ–‰์‹ค์ 

03์ด๊ฒฝ๋ฏธ(237~248)ok

Transcription:

Perspectives in Nursing Science Vol. 14 No. 2, 45-54, October, 2017 ISSN 2288-2898 https://doi.org/10.16952/pns.2017.14.2.45 ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ ์šฉ๋ฐํšจ๊ณผ ์ตœํฌ๊ฐ• 1 ๊ฐ•๋ฏธ์ • 2 ๊ฐ•ํ˜„์ฃผ 2 ๊น€์€ํ˜œ 2 ์„œ์šธ๋Œ€ํ•™๊ต๋ณ‘์›๊ฐ„ํ˜ธ๋ถ€๋ฌธ์ „๊ฐ„ํ˜ธ๊ณผ์žฅ 1, ์„œ์šธ๋Œ€ํ•™๊ต๋ณ‘์›๊ฐ„ํ˜ธ๋ถ€๋ฌธ์ˆ˜๊ฐ„ํ˜ธ์‚ฌ 2 The Application and Effect of the Nursing Protocol of Pediatric Peripheral Intravenous Infusion Choi, Heekang 1 Kang, Mijung 2 Kang, Hyunju 2 Kim, Eunhye 2 1 Ex-Director, Department of Nursing, Seoul National University Hospital, Seoul 2 Unit Manager, Department of Nursing, Seoul National University Hospital, Seoul, Korea Purpose: The aim of this study was to compare the effect of training and implementation of a pediatric peripheral intravenous infusion protocol on the nurses performance and infusion complication rate. Methods: A quasiexperimental study using a posttest comparison of a one group pretest-time series design was utilized. This method was developed to measure nursing knowledge and performance based on a pediatric peripheral intravenous infusion protocol. To calculate the occurrence rate of complications, the number of complications were divided into the number of intravenous insertions. Results: It was shown that the training developed by the study team in 2015 contributed to nurses increased knowledge, as well as improved job performance. Furthermore, the implementation of the protocol revealed that the number of peripheral intravenous insertions, an invasive procedure, decreased. Additionally, the nursing workload related to pediatric intravenous infusions was reduced. Conclusion: This protocol may contribute to the improved scientific quality and efficiency of nursing management of peripheral intravenous infusions. Key Words: Intravenous infusions, Nursing, Clinical protocols, Pediatrics ์„œ๋ก  1. ์—ฐ๊ตฌ์˜ํ•„์š”์„ฑ ์ •๋งฅ์ฃผ์‚ฌ์š”๋ฒ•์€ํ™˜์ž์˜์น˜๋ฃŒ๋ฅผ์œ„ํ•˜์—ฌ์ฃผ์‚ฌ์•ฝ๋ฌผ, ์ˆ˜์•ก, ๋น„๊ฒฝ๊ตฌ์˜์–‘, ํ˜ˆ์•ก์ œ์ œ์˜ํˆฌ์ž…์—๊ด‘๋ฒ”์œ„ํ•˜๊ฒŒ์ด์šฉ๋˜๊ณ ์žˆ์œผ๋ฉฐ์ž…์›ํ™˜์ž์—๊ฒŒ๊ฐ€์žฅ๋นˆ๋ฒˆํ•˜๊ฒŒํ–‰ํ•ด์ง€๋Š”์นจ์Šต์ ์ฒ˜์น˜์ด๋‹ค. 1) ์„ฑ์ธ๋ฟ๋งŒ์•„๋‹ˆ๋ผ์ž…์›ํ•œ์•„๋™์˜๊ฒฝ์šฐ์—๋„์ •๋งฅ์ฃผ์‚ฌ์š”๋ฒ•์€์•ฝ๋ฌผ์ฃผ์ž…์ด๋‚˜์ˆ˜์•ก์ œ์ œ๋“ฑ์˜์ฃผ์ž…, ์‹ฌํ˜ˆ๊ด€๊ณ„์˜์••๋ ฅ์ธก์ •๋˜๋Š”์ฑ„ ํ˜ˆ๋“ฑ์„์œ„ํ•ด์„œ๊ฐ€์žฅํ”ํ•˜๊ฒŒ์‹œ์ˆ ๋˜๋Š”์˜๋ฃŒํ–‰์œ„๋กœ์จ์–ด๋ฆฐ์ด๋ณ‘์›์—์ž…์›ํ•˜๋Š”์•„๋™์ค‘ 63.8% ๊ฐ€์ž…์›์ค‘์—์ฃผ์‚ฌ์š”๋ฒ•์„๋ฐ›์•˜์œผ๋ฉฐ, ์ฃผ๋กœ์•ฝ๋ฌผํˆฌ์—ฌ์™€์ •๋งฅ์œ ์ง€๋ฐ์ฑ„ํ˜ˆ์„์œ„ํ•œ๋ชฉ์ ์œผ๋กœ์‹œํ–‰๋˜์—ˆ๊ณ ์„ฑ์ธ์—๋น„ํ•ด์†Œ์•„๊ฐ€์ •๋งฅ์ฃผ์‚ฌ์š”๋ฒ•์„๋งŽ์ด๋ฐ›๊ณ ์žˆ๋‹ค. 2) ์ •๋งฅ์ฃผ์‚ฌ๋Š”์ •๋งฅ์—ผ๊ณผ์ฃผ์‚ฌ๋ถ€์œ„์˜๋ฐœ์ , ํ†ต์ฆ, ๋ถ€์ข…, ๋ง‰ํž˜, ์นจ์œค๊ณผ๊ฐ™์€ํ•ฉ๋ณ‘์ฆ์„์œ ๋ฐœํ•˜๊ธฐ๋•Œ๋ฌธ์—ํŠน๋ณ„ํ•œ๊ด€๋ฆฌ๊ฐ€์š”๊ตฌ๋œ๋‹ค. 3) ํŠนํžˆ์นจ์œค์€์‹ค์ œ์ž„์ƒ์—์„œ์ •๋งฅ์ฃผ์‚ฌ์ œ๊ฑฐ๋ฅผ์ดˆ๋ž˜ํ•˜๋Š”๊ฐ€์žฅํ”ํ•œ์›์ธ์œผ๋กœ๋ณด๊ณ ๋˜๊ณ ์žˆ๋‹ค. 4,5) ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌํ•ฉ๋ณ‘์ฆ๊ด€๋ จ์—ฐ๊ตฌ๋ฅผ์‚ดํŽด๋ณด๋ฉด, ๊ตญ์™ธ์˜๊ฒฝ์šฐ์ž…์›์•„๋™ 303์ธ์„์กฐ์‚ฌํ•œ์—ฐ ์ฃผ์š”์–ด : ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ, ๊ฐ„ํ˜ธ, ์ž„์ƒํ”„๋กœํ† ์ฝœ, ์•„๋™ Corresponding author: Kang, Mijung Department of Nursing, Seoul National University Hospital, 101 Daehak-ro Jongno-gu, Seoul 03080, Korea. Tel: +82-2-2072-0081, Fax: +82-2-3676-4108, E-mail: kmj3554@naver.com - ๋ณธ์—ฐ๊ตฌ๋Š”์„œ์šธ๋Œ€ํ•™๊ต๋ณ‘์›๊ฐ„ํ˜ธ๋ถ€๋ฌธ์˜์ง€์›์„๋ฐ›์•„์ˆ˜ํ–‰๋˜์—ˆ์Œ. - This study was supported by the Department of Nursing, Seoul National University Hospital fund. ํˆฌ๊ณ ์ผ 2017 ๋…„ 9 ์›” 7 ์ผ / ์‹ฌ์‚ฌ์™„๋ฃŒ์ผ 2017 ๋…„ 9 ์›” 17 ์ผ / ๊ฒŒ์žฌํ™•์ •์ผ 2017 ๋…„ 9 ์›” 21 ์ผ c 2017 The Research Institute of Nursing Science Seoul National University http://rins.snu.ac.kr

์ตœํฌ๊ฐ• ๊ฐ•๋ฏธ์ • ๊ฐ•ํ˜„์ฃผ๋“ฑ ๊ตฌ์—์„œ 41% ์˜ํ•ฉ๋ณ‘์ฆ๋ฐœ์ƒ์„๋ณด๊ณ ํ•˜์˜€์œผ๋ฉฐ, 6) ์žฌํƒœ๊ธฐ๊ฐ„ 26์ฃผ์ดํ•˜์ธ์‹ ์ƒ์•„์ค‘ํ™˜์ž์‹ค๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์š”๋ฒ•์„๋ฐ›๋Š”ํ™˜์•„์˜ 78% ์ด์ƒ์—์„œ์นจ์œค์ด๋ฐœ์ƒํ•˜๋ฉฐ, ์ผํ˜ˆ์€ 11% ๋ฐœ์ƒํ•œ๋‹ค๊ณ ์ถ”์ •ํ•˜์˜€๋‹ค. 7) ๊ตญ๋‚ด์—ฐ๊ตฌ์—์„œ๋„์ •๋งฅ์ฃผ์‚ฌ์ œ๊ฑฐ์ด์œ ์˜ 23.7~48.5% ๊ฐ€์นจ์œค๋“ฑ์˜ํ•ฉ๋ณ‘์ฆ์œผ๋กœ๋ณด๊ณ ๋˜์—ˆ์œผ๋ฉฐ 2,8) ์ด๋ฅผํ†ตํ•ด๊ตญ๋‚ด์™ธ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌํ•ฉ๋ณ‘์ฆ๋ฐœ์ƒ๋ฅ ์ด๋†’์€๊ฒƒ์„์•Œ์ˆ˜์žˆ๋‹ค. ์•„๋™์€์„ฑ์ธ์—๋น„ํ•ดํ”ผํ•˜์ง€๋ฐฉ์ด๋‘๊ป๊ณ ํ˜ˆ๊ด€์ด์•ฝํ•ด์„œ์ •๋งฅ์ฃผ์‚ฌ์˜์‚ฝ์ž…์ด์–ด๋ ค์šธ๋ฟ์•„๋‹ˆ๋ผ, ํ™œ๋™๋Ÿ‰์ด๋งŽ๊ณ ๋‚˜์ด๊ฐ€์–ด๋ฆด์ˆ˜๋กํ˜‘์กฐ๊ฐ€์ด๋ฃจ์–ด์ง€์ง€์•Š์•„์„œ์–ด๋ ต๊ฒŒ์‚ฝ์ž…ํ•œ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ์œ ์ง€ํ•˜๋Š”๊ฒƒ๋„์‰ฝ์ง€์•Š๋‹ค. ์•„๋™์˜๊ฒฝ์šฐํ•ฉ๋ณ‘์ฆ์ด๋ฐœ์ƒํ•˜์ง€์•Š๋Š”ํ•œ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ๊ต์ฒดํ•˜์ง€์•Š์•„๋„๋œ๋‹ค๋Š”๊ฒƒ์ด์ตœ๊ทผ์˜์•„๋™์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์ง€์นจ 8) ์ด์ง€๋งŒ์ž…์›์•„๋™์˜์ •๋งฅ์ฃผ์‚ฌ์œ ์ง€์‹œ๊ฐ„์—๊ด€ํ•œ์—ฐ๊ตฌ 1) ์—๋”ฐ๋ฅด๋ฉด์ž…์›์•„๋™์€๋ง‰ํž˜๊ณผ์นจ์œค, ๋ถ€์ข…์œผ๋กœ์ธํ•ด 72์‹œ๊ฐ„์„์œ ์ง€ํ•˜์ง€๋ชปํ•˜๊ณ ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ์ œ๊ฑฐํ•˜๋Š”์ผ์ด๊ณผ๋ฐ˜์ˆ˜์ด์ƒ์„์ฐจ์ง€ํ•˜๋Š”๋“ฑ์ˆ˜์‹œ๋กœ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ๊ต์ฒดํ•˜๊ณ ์žˆ๋Š”๊ฒƒ์ดํ˜„์‹ค์ด๋‹ค. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์™€๊ด€๋ จ๋œํ•ฉ๋ณ‘์ฆ์„๋ฏธ๋ฆฌ์˜ˆ๋ฐฉํ•˜๊ณ ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„๋ฅผ์•ˆ์ „ํ•˜๊ฒŒ์œ ์ง€ํ•˜๋Š”๋…ธ๋ ฅ์ด๊ฐ„ํ˜ธ์ž„์ƒ์‹ค๋ฌด์—์„œ๊ฐ•์กฐ๋˜๊ณ ์žˆ์œผ๋ฉฐ๊ฐ„ํ˜ธ์‚ฌ๊ฐ€์ •ํ™•ํ•œ์ง€์‹๊ณผํ‘œ์ค€ํ™”๋œ๋ฐฉ๋ฒ•์œผ๋กœ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ๊ด€๋ฆฌํ• ํ•„์š”์„ฑ์ด์ฆ๋Œ€๋˜๊ณ ์žˆ๋‹ค. ์ตœ๊ทผ์—์ˆ˜์šฉ๊ฐœ์ž‘๋ฐฉ๋ฒ•์„์ด์šฉํ•˜์—ฌ๊ทผ๊ฑฐ๊ธฐ๋ฐ˜์ •๋งฅ์ฃผ์ž…์š”๋ฒ•๊ฐ„ํ˜ธ์‹ค๋ฌด์ง€์นจ์ด๊ฐœ๋ฐœ๋˜์—ˆ์œผ๋‚˜ 9) ์„ฑ์ธํ™˜์ž์˜๊ด€๋ฆฌ์—์ดˆ์ ์ด๋งž์ถฐ์ ธ์žˆ์–ด์„ฑ์ธ๊ณผ๋‹ค๋ฅธํŠน์„ฑ์„๊ฐ€์ง„์•„๋™ํ™˜์ž์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—์ ์šฉํ•˜๋Š”๊ฒƒ์—๋Š”์–ด๋ ค์›€์ด์žˆ๋‹ค. ๋˜ํ•œ๊ธฐ์กด์„ ํ–‰์—ฐ๊ตฌ์—๋”ฐ๋ฅด๋ฉดํ‘œ์ค€ํ™”๋œ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์ง€์นจ์„๊ต์œก๋ฐ›์€๊ฐ„ํ˜ธ์‚ฌ์ง‘๋‹จ์€๊ต์œก๋ฐ›์ง€์•Š์€๊ฐ„ํ˜ธ์‚ฌ์—๋น„ํ•ด์ •๋งฅ์ฃผ์‚ฌ์—๋Œ€ํ•œ๊ด€๋ฆฌ๋ฅผ๋”์ž˜ํ•˜๋Š”๊ฒƒ์œผ๋กœ๋‚˜ํƒ€๋‚˜๊ฐ„ํ˜ธ์‚ฌ๊ต์œก์ด์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—์ค‘์š”ํ•จ์„์•Œ์ˆ˜์žˆ๋‹ค. 10) ์ด์—๋ณธ์—ฐ๊ตฌํŒ€์€ 2015๋…„์—์ฒด๊ณ„์ ๋ฌธํ—Œ๊ณ ์ฐฐ๊ณผ๊ธฐ์กด๊ฐ€์ด๋“œ๋ผ์ธ์˜๊ฒ€ํ† , ์ž„์ƒ์ „๋ฌธ๊ฐ€์˜๊ฒฝํ—˜์„ํ†ตํ•ด์•„๋™ํ™˜์ž์˜ํŠน์„ฑ์„๋ฐ˜์˜ํ•œ๊ทผ๊ฑฐ๊ธฐ๋ฐ˜์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์„๊ฐœ๋ฐœํ•˜์˜€๋‹ค. ๊ทธ๋Ÿฌ๋‚˜๊ฐœ๋ฐœ๋œํ”„๋กœํ† ์ฝœ์ ์šฉํšจ๊ณผ์—๋Œ€ํ•œ๊ณผํ•™์ ์ธ๊ฒ€์ฆ์ด์•„์ง์ด๋ฃจ์–ด์ง€์ง€์•Š์€์ƒํ™ฉ์ด๋‹ค. ๋”ฐ๋ผ์„œ๋ณธ์—ฐ๊ตฌ์—์„œ๋Š”์–ด๋ฆฐ์ด๋ณ‘์›์—์„œ๊ทผ๋ฌดํ•˜๋Š”๊ฐ„ํ˜ธ์‚ฌ๋ฅผ๋Œ€์ƒ์œผ๋กœ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์—๋Œ€ํ•œ๊ต์œก์„์‹œํ–‰ํ•˜๊ณ ๊ต์œก์ „, ํ›„๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—๋Œ€ํ•œ๊ฐ„ํ˜ธ์‚ฌ์˜์ง€์‹๊ณผ์ˆ˜ํ–‰๋„๋น„๊ต, ๊ทธ๋ฆฌ๊ณ ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ ์šฉ์ „, ํ›„์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ จ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์„๋น„๊ตํ•˜์—ฌ๊ทธํšจ๊ณผ๋ฅผ์‚ดํŽด๋ณด๊ณ ์žํ•œ๋‹ค. ๊ฒƒ์ด๋‹ค. ์ด๋Ÿฌํ•œ๋ชฉ์ ์„๋‹ฌ์„ฑํ•˜๊ธฐ์œ„ํ•œ์—ฐ๊ตฌ๊ฐ€์„ค์€๋‹ค์Œ๊ณผ๊ฐ™๋‹ค. ๊ฐ€์„ค 1. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ๊ต์œกํ›„์˜๊ฐ„ํ˜ธ์‚ฌ์˜์ง€์‹์ˆ˜์ค€์ด๊ต์œก์ „๋ณด๋‹คํ–ฅ์ƒ๋ ๊ฒƒ์ด๋‹ค. ๊ฐ€์„ค 2. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ๊ต์œกํ›„์˜๊ฐ„ํ˜ธ์‚ฌ์˜ํ”„๋กœํ† ์ฝœ์—๋”ฐ๋ฅธ๊ฐ„ํ˜ธ์ˆ˜ํ–‰๋„๊ฐ€์ ์šฉ์ „๋ณด๋‹คํ–ฅ์ƒ๋ ๊ฒƒ์ด๋‹ค. ๊ฐ€์„ค 3. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ จ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์ด์ ์šฉ์ „๋ณด๋‹ค๊ฐ์†Œ๋ ๊ฒƒ์ด๋‹ค. ์—ฐ๊ตฌ๋ฐฉ๋ฒ• 1. ์—ฐ๊ตฌ์„ค๊ณ„ ๋ณธ์—ฐ๊ตฌ๋Š”์„œ์šธ์‹œ์†Œ์žฌ์ƒ๊ธ‰์ข…ํ•ฉ๋ณ‘์›์˜์–ด๋ฆฐ์ด๋ณ‘์› 4๊ฐœ๋ณ‘๋™์—์„œ๊ทผ๋ฌดํ•˜๊ณ ์žˆ๋Š”๊ฐ„ํ˜ธ์‚ฌ๋ฅผ๋Œ€์ƒ์œผ๋กœ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ๊ต์œก์„์‹œํ–‰ํ•˜๊ณ ๊ต์œก๋ฐ›์€๊ฐ„ํ˜ธ์‚ฌ๋“ค์ด์ด๋ฅผ์—…๋ฌด์—์ ์šฉํ•˜๋„๋กํ•˜์—ฌ๊ต์œก์ „, ํ›„์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธ์—๋Œ€ํ•œ์ง€์‹๊ณผ์ˆ˜ํ–‰๋„๋ฐํ”„๋กœํ† ์ฝœ์ ์šฉ์ „, ํ›„์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ จ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์„๋น„๊ตํ•˜์—ฌ๊ทธํšจ๊ณผ๋ฅผํ™•์ธํ•˜๋Š”๋‹จ์ผ๊ตฐ์‹œ๊ณ„์—ด์„ค๊ณ„์˜์ „ํ›„๋น„๊ต์—์˜ํ•œ์œ ์‚ฌ์‹คํ—˜์—ฐ๊ตฌ์ด๋‹ค. 2. ์—ฐ๊ตฌ๋Œ€์ƒ ํ”„๋กœํ† ์ฝœ๊ต์œก๋ฐ์ ์šฉ์˜ํšจ๊ณผ๋ฅผํ‰๊ฐ€ํ•˜๊ธฐ์œ„ํ•œ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ จ์ง€์‹๊ณผ์ˆ˜ํ–‰๋„๋Š”์„œ์šธ์‹œ์†Œ์žฌ์ƒ๊ธ‰์ข…ํ•ฉ๋ณ‘์›์˜์–ด๋ฆฐ์ด๋ณ‘์›๋‚ด์—ฐ๊ตฌ๋Œ€์ƒ๋ณ‘๋™์œผ๋กœ์ž„์˜์„ ์ •ํ•œ๋‚ด๊ณผ๊ณ„ 2๋ณ‘๋™, ์™ธ๊ณผ๊ณ„ 2๋ณ‘๋™์ด 4๋ณ‘๋™์—์„œ๊ทผ๋ฌดํ•˜๋Š”๊ฐ„ํ˜ธ์‚ฌ์ค‘์ž„์ƒ๊ฒฝ๋ ฅ 3๊ฐœ์›”์ด์ƒ์ด๋ฉฐ์—ฐ๊ตฌ์˜๋ชฉ์ ์„์ดํ•ดํ•˜๊ณ ์ฐธ์—ฌ์—๋™์˜ํ•œ๊ฐ„ํ˜ธ์‚ฌ๋ฅผ๋Œ€์ƒ์œผ๋กœํ•˜์˜€๋‹ค. Cohen 11) ์˜๊ณต์‹์—๋”ฐ๋ผํšจ๊ณผํฌ๊ธฐ๋Š”์ค‘๊ฐ„์ˆ˜์ค€์ธ 0.5, ๊ฒ€์ •๋ ฅ 0.8, ์œ ์˜์ˆ˜์ค€ 0.05๋กœ๊ณ„์‚ฐํ•˜์˜€์„๋•Œ์ค‘์žฌ์ „ํ›„๊ฐ๊ฐ 64๋ช…์ด์ ์ •ํ‘œ๋ณธ์ˆ˜๋กœ์‚ฐ์ถœ๋˜์—ˆ๋‹ค. ์ด 4๊ฐœ๋ณ‘๋™์˜๊ฐ„ํ˜ธ์‚ฌ 62๋ช…์ด์‚ฌ์ „์กฐ์‚ฌ์—์ฐธ์—ฌํ•˜์˜€์œผ๋‚˜์ด์ค‘ 2๋ช…์ดํƒˆ๋ฝํ•˜์—ฌ์ตœ์ข…๋Œ€์ƒ์ž๋Š” 60 ๋ช…์ด์—ˆ๋‹ค. ํ”„๋กœํ† ์ฝœ์ ์šฉ์˜ํšจ๊ณผ๋ฅผํ‰๊ฐ€ํ•˜๊ธฐ์œ„ํ•œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์€์—ฐ๊ตฌ์—์ฐธ์—ฌํ•˜๋Š” 4๊ฐœ์˜๋ณ‘๋™์—์ž…์›ํ•˜์—ฌ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ๊ฐ–๊ณ ์žˆ๋Š”ํ™˜์ž์ „์ˆ˜๋ฅผ๋Œ€์ƒ์œผ๋กœํ•˜์˜€๋‹ค. 2. ์—ฐ๊ตฌ๋ชฉ์ ๋ฐ๊ฐ€์„ค 3. ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ ๋ณธ์—ฐ๊ตฌ์˜๋ชฉ์ ์€์–ด๋ฆฐ์ด๋ณ‘์›๊ฐ„ํ˜ธ์‚ฌ๋ฅผ๋Œ€์ƒ์œผ๋กœ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์„๊ต์œกํ•˜๊ณ ์ ์šฉํ•˜์—ฌ๊ทธํšจ๊ณผ๋ฅผํŒŒ์•…ํ•˜๋Š” ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์€์–ด๋ฆฐ์ด๋ณ‘์›์—์ž…์›ํ•œ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ๋ถ€์ž‘์šฉ์—†์ด์ฒด๊ณ„์ ์œผ๋กœ๊ด€๋ฆฌํ•˜๊ธฐ 46 Perspectives in Nursing Science

์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ ์šฉ๋ฐํšจ๊ณผ ์œ„ํ•œ๋ชฉ์ ์œผ๋กœ 2015๋…„์—๊ฐœ๋ฐœ๋˜์—ˆ๋‹ค. ๋ณธํ”„๋กœํ† ์ฝœ์€๊ตญ์™ธ์—์„œ๊ฐœ๋ฐœ๋œ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ๊ฐ€์ด๋“œ๋ผ์ธ๊ณผ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—ํ™œ์šฉํ• ์ˆ˜์žˆ๋Š”์ตœ์‹ ์˜๊ตญ, ๋‚ด์™ธ๋ฌธํ—Œ์„๊ทผ๊ฑฐ๋กœํ•˜์—ฌ์ดˆ์•ˆ์„๊ฐœ๋ฐœํ•˜์˜€์œผ๋ฉฐ์ „๋ฌธ๊ฐ€์ง‘๋‹จ์˜๋‚ด์šฉํƒ€๋‹น๋„๊ฒ€์ฆ๊ณผ์‚ฌ์šฉ์žํƒ€๋‹น๋„๊ฒ€์ฆ์„ํ†ตํ•ด์ตœ์ข…ํ”„๋กœํ† ์ฝœ์„๊ฐœ๋ฐœํ•˜์˜€๋‹ค. ๋ณธํ”„๋กœํ† ์ฝœ์€๊ต์œก, ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๋ถ€์œ„๋“œ๋ ˆ์‹ฑ๊ณผ๊ณ ์ •, ์œ ์ง€๋ฐ๊ด€๋ฆฌ, ๊ด€์ฐฐ๊ณผ๊ธฐ๋ก, ๋ถ€์ž‘์šฉ์‹œ๋Œ€์ฒ˜๋ฐฉ์•ˆ๋“ฑ์ด 5๊ฐœ์˜์—ญ, 46๊ฐœ์˜๊ถŒ๊ณ ์•ˆ์œผ๋กœ๊ตฌ์„ฑ๋˜์–ด์žˆ๋‹ค. ์œ„๊ด€์ฐฐ๊ธฐ๋ก์ง€๋Š”์—ฐ๊ตฌ๋Œ€์ƒ๋ณ‘๋™๊ฐ„ํ˜ธ์‚ฌ๊ฐ€๋งค๊ทผ๋ฌด์กฐ๋งˆ๋‹ค๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๋ฐ์œ ์ง€์—ฌ๋ถ€, ๋ถ€์ž‘์šฉ๋ฐœ์ƒ์—ฌ๋ถ€, ๋ถ€์ž‘์šฉ๋ฐœ์ƒ์‹œ๋ถ€์ž‘์šฉ์˜์ข…๋ฅ˜๋ฐ์ •๋„, ๋ถ€์ž‘์šฉ์‹œ์ค‘์žฌ๋‚ด์šฉ, ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์ œ๊ฑฐ์‚ฌ์œ ๋“ฑ์„๊ธฐ๋กํ•˜๋„๋กํ•˜์˜€๋‹ค. ๊ธฐ๋ก์ง€๋ถ„์„์„ํ†ตํ•ดํŒŒ์•…๋œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ๊ฑด์ˆ˜๋ฅผ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๊ฑด์ˆ˜๋กœ๋‚˜๋ˆ„์–ด๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์„์‚ฐ์ถœํ•˜์˜€๋‹ค. 5. ์ž๋ฃŒ์ˆ˜์ง‘ 4. ์—ฐ๊ตฌ๋„๊ตฌ 1) ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—๋Œ€ํ•œ์ง€์‹ 2015๋…„์„œ์šธ์‹œ์†Œ์žฌ์ƒ๊ธ‰์ข…ํ•ฉ๋ณ‘์›์˜์–ด๋ฆฐ์ด๋ณ‘์›์—์„œ๊ฐœ๋ฐœํ•œ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์„ํ† ๋Œ€๋กœ 10๋ฌธํ•ญ์˜์ง€์‹์ธก์ •๋„๊ตฌ๋ฅผ๊ฐœ๋ฐœํ•˜์˜€์œผ๋ฉฐ๊ฐœ๋ฐœํ•œ์ธก์ •๋„๊ตฌ๋Š”์–ด๋ฆฐ์ด๋ณ‘์›์ˆ˜๊ฐ„ํ˜ธ์‚ฌ 3์ธ๊ณผ๊ฐ„ํ˜ธ๋Œ€ํ•™๊ต์ˆ˜ 1์ธ, ์ •๋งฅ์ฃผ์‚ฌํŒ€๊ฐ„ํ˜ธ์‚ฌ 1์ธ์—๊ฒŒ๋‚ด์šฉํƒ€๋‹น๋„๋ฅผ๊ฒ€์ฆ๋ฐ›์•„์ˆ˜์ • ๋ณด์™„ํ•˜์˜€๋‹ค. ๊ฐํ•ญ๋ชฉ๋ณ„ CVI ๊ฐ’์€ 0.8~1.0์˜๋ถ„ํฌ๋ฅผ๋ณด์˜€์œผ๋ฉฐ์ „์ฒดํ•ญ๋ชฉ์—๋Œ€ํ•œ CVI ๊ฐ’์€ 0.96์ด์—ˆ๋‹ค. ๊ฐ๋ฌธํ•ญ์€๋งž๋‹ค, ํ‹€๋ฆฌ๋‹ค, ๋ชจ๋ฅธ๋‹ค๋กœ๊ตฌ๋ถ„ํ•˜์—ฌ๋‹ตํ•˜๋„๋กํ•˜์˜€์œผ๋ฉฐ๋งž์€๋ฌธํ•ญ์€ 1์ , ํ‹€๋ฆฌ๊ฑฐ๋‚˜๋ชจ๋ฅธ๋‹ค๋กœ๋‹ตํ•œ๊ฒฝ์šฐ์—๋Š” 0์ ์„์ฃผ์—ˆ๋‹ค. ์ ์ˆ˜๋ฒ”์œ„๋Š”์ตœ์†Œ 0์ ์—์„œ์ตœ๋Œ€ 10์ ๊นŒ์ง€๋ฉฐ, ์ ์ˆ˜๊ฐ€๋†’์„์ˆ˜๋ก์ง€์‹์ •๋„๊ฐ€๋†’์Œ์„์˜๋ฏธํ•œ๋‹ค. 2) ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ˆ˜ํ–‰๋„ 2015๋…„์„œ์šธ์‹œ์†Œ์žฌ์ƒ๊ธ‰์ข…ํ•ฉ๋ณ‘์›์˜์–ด๋ฆฐ์ด๋ณ‘์›์—์„œ๊ฐœ๋ฐœํ•œ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์„ํ† ๋Œ€๋กœ์ด 37๋ฌธํ•ญ์˜์ˆ˜ํ–‰๋„์ธก์ •๋„๊ตฌ๋ฅผ๊ฐœ๋ฐœํ•˜์˜€๋‹ค. ์ธก์ •๋„๊ตฌ๋Š”ํ”„๋กœํ† ์ฝœ์˜๊ฐ์˜์—ญ๋ณ„๋กœ๊ณ ๋ฃจ๋ถ„ํฌ๋˜๋„๋กํ•˜์˜€์œผ๋ฉฐ๊ต์œก์˜์—ญ 2๋ฌธํ•ญ, ๋“œ๋ ˆ์‹ฑ๊ณผ๊ณ ์ •์˜์—ญ 7๋ฌธํ•ญ, ์œ ์ง€์™€๊ด€๋ฆฌ์˜์—ญ 7๋ฌธํ•ญ, ๊ด€์ฐฐ๊ณผ๊ธฐ๋ก 9๋ฌธํ•ญ, ํ•ฉ๋ณ‘์ฆ๊ด€๋ฆฌ 12๋ฌธํ•ญ์œผ๋กœ๊ตฌ์„ฑํ•˜์˜€๋‹ค. ์ด์ธก์ •๋„๊ตฌ๋ฅผ์–ด๋ฆฐ์ด๋ณ‘์›์ˆ˜๊ฐ„ํ˜ธ์‚ฌ 3์ธ๊ณผ๊ฐ„ํ˜ธ๋Œ€ํ•™๊ต์ˆ˜ 1์ธ, ์ •๋งฅ์ฃผ์‚ฌํŒ€๊ฐ„ํ˜ธ์‚ฌ 1์ธ์—๊ฒŒ๋‚ด์šฉํƒ€๋‹น๋„๋ฅผ๊ฒ€์ฆ๋ฐ›์•„์ˆ˜์ • ๋ณด์™„ํ•˜์˜€๋‹ค. ๊ฐํ•ญ๋ชฉ๋ณ„ CVI ๊ฐ’์€ 0.8~1.0์˜๋ถ„ํฌ๋ฅผ๋ณด์˜€์œผ๋ฉฐ์ „์ฒดํ•ญ๋ชฉ์—๋Œ€ํ•œ CVI ๊ฐ’์€ 0.97์ด์—ˆ๋‹ค. ๊ฐ๋ฌธํ•ญ์€ ์ „ํ˜€์ˆ˜ํ–‰ํ•˜์ง€์•Š์Œ 1์ ์—์„œ ํ•ญ์ƒ์ˆ˜ํ–‰ 4์ ๊นŒ์ง€์˜ 4์  Likert ์ฒ™๋„๋กœ๊ตฌ์„ฑ๋˜์—ˆ์œผ๋ฉฐ์ ์ˆ˜๊ฐ€๋†’์„์ˆ˜๋ก์ˆ˜ํ–‰๋„๊ฐ€๋†’์Œ์„์˜๋ฏธํ•œ๋‹ค. ๋ณธ๋„๊ตฌ์˜์‹ ๋ขฐ๋„ Cronbach s ๋Š”.92์˜€๋‹ค. 3) ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์€์—ฐ๊ตฌ์ž๊ฐ€๊ฐœ๋ฐœํ•œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„๊ด€์ฐฐ๊ธฐ๋ก์ง€๋ฅผ์‚ฌ์šฉํ•˜์—ฌ์ธก์ •ํ•˜์˜€๋‹ค. ์ •๋งฅ์ฃผ์‚ฌ๋ถ€ 1) ์—ฐ๊ตฌ์˜์œค๋ฆฌ์ ๊ณ ๋ ค๋ณธ์—ฐ๊ตฌ๋Š”์—ฐ๊ตฌ์ฐธ์—ฌ์ž๋“ค์˜์œค๋ฆฌ์ ์ธก๋ฉด์„๋ณดํ˜ธํ•˜๊ธฐ์œ„ํ•ด์—ฐ๊ตฌ์‹œ์ž‘์ „ํ•ด๋‹น๋ณ‘์›์˜์ž„์ƒ์‹œํ—˜์œค๋ฆฌ์œ„์›ํšŒ์˜์Šน์ธ์„๋ฐ›์€ํ›„์ž๋ฃŒ๋ฅผ์ˆ˜์ง‘ํ•˜์˜€๋‹ค (IRB No. 1606-093-771). ์ž๋ฃŒ๋ฅผ์ˆ˜์ง‘ํ•˜๊ธฐ์œ„ํ•˜์—ฌ์—ฐ๊ตฌ์ž๊ฐ€๋ณธ์—ฐ๊ตฌ๋Œ€์ƒ์ž๊ฐ€๊ทผ๋ฌดํ•˜๋Š”๋ณ‘๋™์˜๋‚ฎ๋ฒˆ ์ดˆ๋ฒˆ์ธ์ˆ˜์ธ๊ณ„์‹œ๊ฐ„์—์ƒ๊ธ‰์ž์—์˜ํ•œ๊ฐ•์ œ์„ฑ์„๋ฐฐ์ œํ•˜๊ธฐ์œ„ํ•ดํ•ด๋‹น์ˆ˜๊ฐ„ํ˜ธ์‚ฌ๊ฐ€๋ฐฐ์„ํ•˜์ง€์•Š์€์ƒํƒœ์—์„œ์—ฐ๊ตฌ๋Œ€์ƒ์ž์ธ๊ฐ„ํ˜ธ์‚ฌ๋“ค์—๊ฒŒ์—ฐ๊ตฌ๋ชฉ์ ์„์„ค๋ช…ํ•˜๊ณ , ์ž์‹ ์˜์˜์ง€์—๋”ฐ๋ผ์ž์œ ๋กญ๊ฒŒ์—ฐ๊ตฌ์—์ฐธ์—ฌ๊ฐ€๋Šฅํ•˜๋ฉฐ, ์—ฐ๊ตฌ์—๋™์˜ํ•˜์ง€์•Š๋Š”๊ฒฝ์šฐ์—ฐ๊ตฌ์—์ฐธ์—ฌํ•˜์ง€์•Š์•„๋„๊ฐœ์ธ์ ๋ถˆ์ด์ต์ด์—†์Œ์„์„ค๋ช…ํ•˜์˜€๊ณ , ๋‹ค์Œ๋‚ ๋™์˜์—ฌ๋ถ€๋ฅผ๊ฒฐ์ •ํ•˜๋„๋กํ•˜์˜€๋‹ค. ํšŒ์ˆ˜๋œ์„ค๋ฌธ์ง€๋Š”๋Œ€์ƒ์ž๋ฅผ์‹๋ณ„ํ• ์ˆ˜์—†๋„๋ก์ฝ”๋“œํ™”ํ•˜์—ฌ์ต๋ช…์„ฑ์„์œ ์ง€ํ• ๊ฒƒ์ด๋‹ค. ํ”„๋กœํ† ์ฝœ์ ์šฉ์ „ํ›„๋กœ์ˆ˜์ง‘ํ•œ๋Œ€์ƒ์ž์˜๊ฐœ์ธ์‹ ์ƒ์ •๋ณด๋Š”๊ธฐ๋ก์˜๋น„๋ฐ€์„์œ„ํ•ด์•”ํ˜ธ๋กœ๋ณด์•ˆ๋œํŒŒ์ผ์—์ €์žฅํ•˜์—ฌ์—ฐ๊ตฌ์ž์™ธ์—๋Š”๋…ธ์ถœํ•˜์ง€์•Š์•˜์œผ๋ฉฐ์—ฐ๊ตฌ๊ด€๋ จ๊ธฐ๋ก์€์—ฐ๊ตฌ๊ฐ€์ข…๋ฃŒ๋œ์‹œ์ ๋ถ€ํ„ฐ 3๋…„๊ฐ„๋ณด๊ด€ํ•˜๋ฉฐ, ๋ณด๊ด€๊ธฐ๊ฐ„์ด์ง€๋‚œ๋ฌธ์„œ์ค‘๊ฐœ์ธ์ •๋ณด์—๊ด€ํ•œ์‚ฌํ•ญ์€๊ฐœ์ธ์ •๋ณด๋ณดํ˜ธ๋ฒ•์—๋”ฐ๋ผํŒŒ๊ธฐํ• ๊ฒƒ์ด๋‹ค. 2) ์ž๋ฃŒ์ˆ˜์ง‘์ ˆ์ฐจ๋ณธ์—ฐ๊ตฌ์˜์ž๋ฃŒ์ˆ˜์ง‘๊ธฐ๊ฐ„์€ 2016๋…„ 8์›”๋ถ€ํ„ฐ 2016๋…„ 10์›”๊นŒ์ง€ 3๊ฐœ์›”๊ฐ„์ด์—ˆ์œผ๋ฉฐ, ๊ตฌ์ฒด์ ์ธ์ ˆ์ฐจ๋Š”๋‹ค์Œ๊ณผ๊ฐ™๋‹ค (Table 1). (1) ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ๋ชจ๋‹ˆํ„ฐ๋งํ”„๋กœํ† ์ฝœ์ ์šฉ์ „, ํ›„์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ์€์—ฐ๊ตฌ๋Œ€์ƒ๋ณ‘๋™๊ฐ„ํ˜ธ์‚ฌ๊ฐ€์ž‘์„ฑํ•œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„๊ด€์ฐฐ๊ธฐ๋ก์ง€๋ฅผ์ด์šฉํ•˜์—ฌํŒŒ์•…ํ•˜์˜€๋‹ค. ๋ถ€์ž‘์šฉ์˜์ข…๋ฅ˜๋ฐ๋‹จ๊ณ„๋ฅผํŒŒ์•…ํ•˜๊ธฐ์œ„ํ•ด 2015๋…„์„œ์šธ์‹œ์†Œ์žฌ์ƒ๊ธ‰์ข…ํ•ฉ๋ณ‘์›์˜์–ด๋ฆฐ์ด๋ณ‘์›์—์„œ๊ฐœ๋ฐœํ•œ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์—์ œ์‹œ๋œ์ •๋งฅ์—ผ์‚ฌ์ •๋„๊ตฌ, ์นจ์œค๋ฐ์ผํ˜ˆ์‚ฌ์ •๋„๊ตฌ๋ฅผ์ด์šฉํ•˜๋„๋กํ•˜์˜€๋‹ค. ๋งค๊ทผ๋ฌด์‹œ๋งˆ๋‹ค 1ํšŒ์ด์ƒ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„๊ด€์ฐฐ๊ธฐ๋ก์ง€์—๊ด€์ฐฐ์‚ฌํ•ญ์„๊ธฐ๋กํ•˜๋„๋กํ•˜์˜€์œผ๋ฉฐ์—ฐ๊ตฌ์ž๊ฐ€๋‹ค์Œ๋‚ ๊ธฐ๋ก์ง€๋ฅผ์ˆ˜๊ฑฐํ•˜๋ฉด์„œ๋ˆ„๋ฝ๋œํ•ญ๋ชฉ์€์ง์ ‘๊ฐ„ํ˜ธ์‚ฌ์—๊ฒŒ๋ฌผ์–ด๋ณด๊ฑฐ๋‚˜์˜๋ฌด๊ธฐ๋ก์„ํ™•์ธํ•˜ Vol. 14 No. 2, 2017 47

์ตœํฌ๊ฐ• ๊ฐ•๋ฏธ์ • ๊ฐ•ํ˜„์ฃผ๋“ฑ Table 1. Flow of Data Collection Items Knowlege evaluation Prior to application Education Application 8/1~8/14 8/15~8/28 8/29~9/9 9/19~10/2 10/3~10/16 10/16~10/18 (Pretest) (Posttest) (Posttest) Performance evaluation (Pretest) (Posttest) Protocol education Application Monitoring side effect ์˜€๋‹ค. ํ”„๋กœํ† ์ฝœ์ ์šฉ์ „ 4์ฃผ์™€๊ต์œกํ›„ํ”„๋กœํ† ์ฝœ์ด์ ์šฉ๋˜๋Š” 4 ์ฃผ๋™์•ˆ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ์„๋ชจ๋‹ˆํ„ฐ๋งํ•˜์˜€์œผ๋ฉฐ, ๊ฐ๊ธฐ๊ฐ„์€ 2์ฐจ์—๋‚˜๋ˆ„์–ด์ง„ํ–‰ํ•˜์˜€๋‹ค. ์‚ฌ์ „์กฐ์‚ฌ๊ธฐ๊ฐ„์€ํ”„๋กœํ† ์ฝœ์ ์šฉ์ „์ธ 8์›” 1์ผ๋ถ€ํ„ฐ 14์ผ, ๊ทธ๋ฆฌ๊ณ  15์ผ๋ถ€ํ„ฐ 28์ผ์ด์—ˆ์œผ๋ฉฐ์‚ฌํ›„์กฐ์‚ฌ๊ธฐ๊ฐ„์€ํ”„๋กœํ† ์ฝœ์ ์šฉ๊ธฐ๊ฐ„์ธ 9์›” 19์ผ๋ถ€ํ„ฐ 10์›” 2์ผ, ๊ทธ๋ฆฌ๊ณ  10์›” 3์ผ๋ถ€ํ„ฐ 16์ผ๊นŒ์ง€์˜€๋‹ค. ์ž‘์„ฑ์ด์™„๋ฃŒ๋œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„๊ด€์ฐฐ๊ธฐ๋ก์ง€๋Š”๊ฐ๋ณ‘๋™์—๋ณ„๋„๋กœ์„ค์น˜๋œ๊ธฐ๋ก์ง€์ˆ˜๊ฑฐํ•จ์—๋„ฃ๊ฒŒํ•˜์˜€์œผ๋ฉฐ์—ฐ๊ตฌ์ž๊ฐ€๋งค์ผ๋ณ‘๋™์„์ˆœํšŒํ•˜๋ฉด์„œ์ˆ˜๊ฑฐํ•˜์˜€๋‹ค. (2) ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์—๋Œ€ํ•œ์ง€์‹ํ‰๊ฐ€๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์—๋Œ€ํ•œ์ง€์‹์‚ฌ์ „ํ‰๊ฐ€๋Š”ํ”„๋กœํ† ์ฝœ๊ต์œก์ „์—์‹œํ–‰ํ•˜์˜€์œผ๋ฉฐ, ๊ต์œก์ด๋๋‚œ์งํ›„ 1์ฐจ์‚ฌํ›„ํ‰๊ฐ€๋ฅผ, ๊ทธ๋ฆฌ๊ณ  4์ฃผ๊ฐ„์˜ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„ 2์ฐจ์‚ฌํ›„ํ‰๊ฐ€๋ฅผ์‹œํ–‰ํ•˜์˜€๋‹ค. (3) ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์—๋Œ€ํ•œ์ˆ˜ํ–‰๋„ํ‰๊ฐ€๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์—๋Œ€ํ•œ์ˆ˜ํ–‰๋„์‚ฌ์ „ํ‰๊ฐ€๋Š”ํ”„๋กœํ† ์ฝœ๊ต์œก์ „์—์‹œํ–‰ํ•˜์˜€์œผ๋ฉฐ, 4์ฃผ๊ฐ„์˜ํ”„๋กœํ† ์ฝœ์ ์šฉ์ด๋๋‚œ 10์›” 16์ผ๋ถ€ํ„ฐ 18์ผ๊นŒ์ง€์‚ฌํ›„ํ‰๊ฐ€๋ฅผ์ง„ํ–‰ํ•˜์˜€๋‹ค. (4) ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ๊ต์œกํ”„๋กœํ† ์ฝœ๊ต์œก์€ 8์›” 29์ผ๋ถ€ํ„ฐ 9์›” 9์ผ๊นŒ์ง€์ด 8ํšŒ์—๊ฑธ์ณ์‹œํ–‰๋˜์—ˆ๋‹ค. ์ฐธ์„์ธ์›์€์ตœ์†Œ 5๋ช…์—์„œ์ตœ๊ณ  11๋ช…์ด์—ˆ์œผ๋ฉฐ๊ต์œก์žฅ์†Œ๋Š”์–ด๋ฆฐ์ด๋ณ‘์›ํšŒ์˜์‹ค์„์ด์šฉํ•˜์˜€๋‹ค. 8ํšŒ์—๊ฑธ์นœ๊ต์œก์—์ด 62๋ช…์˜๋Œ€์ƒ์ž์ „์›์ด์ฐธ์„ํ•˜์˜€์œผ๋ฉฐ๊ต์œก์€์ดˆ๋ฒˆ๊ทผ๋ฌด์ „์˜คํ›„ 2์‹œ๋ถ€ํ„ฐ์•ฝ 30๋ถ„๋™์•ˆ์‹œํ–‰ํ•˜์˜€์œผ๋ฉฐ, ๊ต์œก์ „์ผ๋ฐ˜์ ํŠน์„ฑ์„ํฌํ•จํ•œ์‚ฌ์ „์„ค๋ฌธ์ž‘์„ฑ 5๋ถ„, ๊ต์œก 20๋ถ„, ์งˆ์˜๋ฐ์‚ฌํ›„์„ค๋ฌธ์ž‘์„ฑ 5๋ถ„๋“ฑ์˜์ˆœ์„œ๋กœ์ง„ํ–‰ํ•˜์˜€๋‹ค. ์–ด๋ฆฐ์ด๋ณ‘์›๊ฒฝ๋ ฅ 14๋…„์˜์ˆ˜๊ฐ„ํ˜ธ์‚ฌ 1์ธ์ด๊ต์œก์„์‹œํ–‰ํ•˜์˜€์œผ๋ฉฐ๋™์ผํ•œ๊ต์œก์ž๊ฐ€ 8ํšŒ๊ต์œก์„๋ชจ๋‘์‹œํ–‰ํ•˜์—ฌ๊ต์œก์˜์ผ๊ด€์„ฑ์„์œ ์ง€ํ•˜๋„๋กํ•˜์˜€๋‹ค. ๋˜ ๋‹ค๋ฅธ์—ฐ๊ตฌ์ž 1์ธ์ด์›ํ™œํ•œ๊ต์œก์ง„ํ–‰๊ณผ๋Œ€์ƒ์ž๋“ค์˜์„ค๋ฌธ์ง€์ž‘์„ฑ๋“ฑ์„๋•๊ธฐ์œ„ํ•ด๋ฐฐ์„ํ•˜์˜€๋‹ค. (5) ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ ์šฉ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌํ”„๋กœํ† ์ฝœ์ ์šฉ์€ํ”„๋กœํ† ์ฝœ๊ต์œก์„๋ฐ›์€๊ฐ„ํ˜ธ์‚ฌ๊ฐ€๊ทผ๋ฌดํ•˜๋Š” 4๊ฐœ๋ณ‘๋™์—์„œ 9์›” 19์ผ๋ถ€ํ„ฐ 4์ฃผ๋™์•ˆ์ง„ํ–‰๋˜์—ˆ๋‹ค. ํ”„๋กœํ† ์ฝœ์ ์šฉ์ผ์ฃผ์ผ์ „์—์—ฐ๊ตฌํŒ€์ด์ •๋งฅ์ฃผ์‚ฌํŒ€์„๋งŒ๋‚˜์—ฐ๊ตฌ์˜๋ชฉ์ ๊ณผํ”„๋กœํ† ์ฝœ๋‚ด์šฉ์—๋Œ€ํ•ด์„ค๋ช…ํ•˜๊ณ ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๋ถ€์œ„๋ฅผ๊ด€์ฐฐํ• ์ˆ˜์žˆ๋„๋กํˆฌ๋ช…๋“œ๋ ˆ์‹ฑ์„์‹œํ–‰ํ• ๊ฒƒ์„์š”์ฒญํ•˜์˜€๋‹ค. ํ”„๋กœํ† ์ฝœ์ ์šฉ์ „๋‚ ๊ฐ๊ทผ๋ฌดํŒ€์—๊ฒŒ๋ณดํ˜ธ์ž๊ต์œก์„์œ„ํ•œ๋ณดํ˜ธ์ž์šฉ๊ต์œก์ž๋ฃŒ๋ฅผ๋ฐฐ๋ถ€ํ•˜์˜€๋‹ค. ๋˜ํ•œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๋ถ€์œ„์˜์ƒํƒœ๋ฅผ์ •ํ™•ํ•˜๊ฒŒ์‚ฌ์ •ํ•˜๊ธฐ์œ„ํ•ด Tofani ๋“ฑ์ด๊ฐœ๋ฐœํ•œ touch-look-compare method์™€์ •๋งฅ์—ผ๋ฐœ์ƒ๊ณผ์—ฐ๊ด€์ด์žˆ๋Š”์•ฝ๋ฌผ์„์œ„ํ—˜๋„์—๋”ฐ๋ผ Red, Yellow, Green์œผ๋กœ๋ถ„๋ฅ˜ํ•˜์—ฌ์ •๋ฆฌํ•œ์•ฝ๋ฌผ์‹ ํ˜ธ๋“ฑ, ๊ทธ๋ฆฌ๊ณ ์ •๋งฅ์—ผ์‚ฌ์ •๋„๊ตฌ์ธ VIP (Visual Infusion Phlebitis) score์™€์นจ์œค์‚ฌ์ •๋„๊ตฌ์ธ Infiltration/Extravasation staging, ๋ถ€์ž‘์šฉ์‹œ๋Œ€์ฒ˜์•Œ๊ณ ๋ฆฌ์ฆ˜์„ํฌํ•จํ•œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์„๊ฐ๊ทผ๋ฌดํŒ€๋ณ„๋กœ EMR cart ์˜†์—์†Œ์ง€ํ•˜๊ฒŒํ•˜์—ฌ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„๋ฅผ์ •ํ™•ํ•˜๊ณ ๊ฐ๊ด€์ ์œผ๋กœ์‚ฌ์ •ํ• ์ˆ˜์žˆ๋„๋กํ•˜์˜€์œผ๋ฉฐ, ๋ถ€์ž‘์šฉ๋“ฑ์˜๋ฌธ์ œ๋ฐœ์ƒ์‹œ์ฆ‰๊ฐ์ ์ธ์˜์‚ฌ๊ฒฐ์ •์„ํ• ์ˆ˜์žˆ๋„๋กํ•˜์˜€๋‹ค. 6. ์ž๋ฃŒ๋ถ„์„์ˆ˜์ง‘๋œ์ž๋ฃŒ๋Š” SPSS/WIN Statistics 23.0 ํ”„๋กœ๊ทธ๋žจ์„์ด์šฉํ•˜์—ฌ๋‹ค์Œ๊ณผ๊ฐ™์ด๋ถ„์„ํ•˜์˜€๋‹ค. ์—ฐ๊ตฌ๋Œ€์ƒ์ž์˜ํŠน์„ฑ์€๊ธฐ์ˆ ํ†ต๊ณ„๋ฅผ์ด์šฉํ•˜์—ฌ๋ถ„์„ํ•˜์˜€๋‹ค. ์ค‘์žฌ์ ์šฉ์ „ํ›„์˜์ง€์‹์˜์ฐจ์ด๋Š” ANOVA๋ฅผ์ด์šฉํ•˜์—ฌ๋ถ„์„ํ•˜์˜€๊ณ , ์‚ฌํ›„๊ฒ€์ฆ์œผ๋กœ Scheffe test๋ฅผ์‚ฌ์šฉํ•˜์˜€๋‹ค. 48 Perspectives in Nursing Science

์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ ์šฉ๋ฐํšจ๊ณผ ์ค‘์žฌ์ ์šฉ์ „ํ›„์˜์ˆ˜ํ–‰๋„์˜์ฐจ์ด๋Š” Independent t-test๋ฅผ์ด์šฉํ•˜์—ฌ๋ถ„์„ํ•˜์˜€๋‹ค. ์ค‘์žฌ์ „ํ›„์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์˜๋น„๊ต๋Š” x 2 test๋ฅผ์ด์šฉํ•˜์—ฌ๋ถ„์„ํ•˜์˜€๋‹ค. ์—ฐ๊ตฌ๋„๊ตฌ์˜์‹ ๋ขฐ๋„๋ถ„์„์€ Cronbach s ๋กœ์ธก์ •ํ•˜์˜€๋‹ค. ์—ฐ๊ตฌ๊ฒฐ๊ณผ 1. ๋Œ€์ƒ์ž์˜์ผ๋ฐ˜์ ํŠน์„ฑ ์—ฐ๋ น๋Œ€๋ณ„๋กœ๋Š” 30์„ธ๋ฏธ๋งŒ์ด 25๋ช… (41.7%), 30์„ธ์ด์ƒ์ด 35๋ช… (58.3%) ์ด์—ˆ์œผ๋ฉฐ, ํ‰๊ท ์—ฐ๋ น์€ 31.51±6.05์„ธ๋กœ 23์„ธ์—์„œ 53 ์„ธ๊นŒ์ง€์‘๋‹ตํ•˜์˜€๋‹ค. ํ‰๊ท ๊ทผ๋ฌด๊ฒฝ๋ ฅ์€ 6.70±5.92๋…„๋กœ 1๋…„๋ฏธ๋งŒ์ด 18.3%, 1๋…„์ด์ƒ 3๋…„๋ฏธ๋งŒ์ด 16.7%, 3๋…„์ด์ƒ 5๋…„๋ฏธ๋งŒ์ด 6.7%, 5๋…„์ด์ƒ 7๋…„๋ฏธ๋งŒ์ด 13.3% ์˜€๋‹ค. ์–ด๋ฆฐ์ด๋ณ‘์›๊ทผ๋ฌด๊ฒฝ๋ ฅ์€ํ‰๊ท  4.42±5.15๋…„์ด์—ˆ์œผ๋ฉฐ, 1๋…„๋ฏธ๋งŒ์ด 21.7%, 1๋…„์ด์ƒ 3๋…„๋ฏธ๋งŒ์ด 25.0%, 3๋…„์ด์ƒ 5๋…„๋ฏธ๋งŒ์ด 13.3%, 5๋…„์ด์ƒ 7๋…„๋ฏธ๋งŒ์ด 21.7%, 7๋…„์ด์ƒ์ด 18.3% ์˜€๋‹ค (Table 2). ๋ ๊ฒƒ์ด๋‹ค ๋ผ๋Š”๊ฐ€์„ค 1์€์ง€์ง€๋˜์—ˆ๋‹ค (p<.000)(table 3). ์‚ฌํ›„๊ฒ€์ •์—์„œ๊ต์œก์ „์ง€์‹์ด์ ๋ณด๋‹ค๊ต์œก์งํ›„์™€ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์ง€์‹์ด์ ์ดํ†ต๊ณ„์ ์œผ๋กœ์œ ์˜ํ•˜๊ฒŒ์ฆ๊ฐ€ํ•˜์˜€์œผ๋ฉฐ๊ต์œก์งํ›„์™€ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์˜์ง€์‹์ด์ ์€ํ†ต๊ณ„์ ์œผ๋กœ์œ ์˜ํ•œ์ฐจ์ด๊ฐ€์—†์—ˆ๋‹ค. ๋ฌธํ•ญ๋ณ„๋กœ๋น„๊ตํ•œ๊ฒฐ๊ณผ์ด 10๊ฐœ๋ฌธํ•ญ์ค‘ ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๋ถ€์œ„๋Š”๋ฉธ๊ท ๋“œ๋ ˆ์‹ฑ (sterile dressing) ํ•œ๋‹ค, ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๋ถ€์œ„์˜๋“œ๋ ˆ์‹ฑ๊ตํ™˜์€์ •๊ธฐ์ ์œผ๋กœ์‹œํ–‰ํ•œ๋‹ค, ๋ถ€๋ชฉ (arm board) ์„์ด์šฉํ•œ๊ณ ์ •์‹œํ”ผ๋ถ€์ˆœํ™˜์„ํ™•์ธํ•˜๊ธฐ์œ„ํ•ดํ™˜์ž์˜์†๊ฐ€๋ฝ๊ณผ๋ฐœ๊ฐ€๋ฝ์ด๋ณด์ด๋„๋ก๊ณ ์ •ํ•œ๋‹ค, ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋Š” 3-4์ผ๋งˆ๋‹ค์ฃผ๊ธฐ์ ์œผ๋กœ๊ตํ™˜ํ•œ๋‹ค, ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„์˜๋ถ€์ž‘์šฉ๋ฐœ์ƒ์‹œ์ฆ‰์‹œ IV๋ฅผ์ œ๊ฑฐํ•œ๋‹ค, ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ตํ™˜์‹œ์ˆ˜์•ก์„ธํŠธ๋„๊ฐ™์ด๊ตํ™˜ํ•œ๋‹ค, ๊ฐœ๋ฐฉ์„ฑ์œ ์ง€ (IV patency) ๋ฅผ์œ„ํ•ด๋งค๊ทผ๋ฌด์กฐ๋งˆ๋‹ค์ƒ๋ฆฌ์‹์—ผ์ˆ˜๋ฅผ์ด์šฉํ•˜์—ฌ์ •๋งฅ๊ด€๊ด€๋ฅ˜ (flushing) ๋ฅผ์‹œํ–‰ํ•œ๋‹ค ๋Š” 7๊ฐœ์˜๋ฌธํ•ญ์—๋Œ€ํ•œ์ ์ˆ˜๊ฐ€ํ”„๋กœํ† ์ฝœ๊ต์œก์ „์—๋น„ํ•˜์—ฌ๊ต์œก์งํ›„์™€ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์—ํ†ต๊ณ„์ ์œผ๋กœ์œ ์˜ํ•˜๊ฒŒ์ƒ์Šนํ•˜์˜€๋‹ค. 3. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์—๋Œ€ํ•œ์ˆ˜ํ–‰๋„ Table 2. General Characteristics of the Nurses (N=60) Variables Categories n (%) M±SD Age (year) >30 25 (41.7) 31.51±6.05 30 35 (58.3) Gender Female 60 (100.0) Education Entire working experience (year) Working experience* (year) *Only a children hospital. College Bachelor <1 1~<2 3~<4 5~<7 7 <1 1~<2 3~<4 5~<7 7 9 (15.0) 51 (85.0) 11 (18.3) 10 (16.7) 4 (6.7) 8 (13.3) 27 (45.0) 13 (21.7) 15 (25.0) 8 (13.3) 13 (21.7) 11 (18.3) 6.70±5.92 4.42±5.15 ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ˆ˜ํ–‰๋„์—๊ด€ํ•œ 37๋ฌธํ•ญ์˜์ „์ฒดํ‰๊ท ์ ์ˆ˜๋Š”๊ต์œก์ „ 3.14±0.35์ ์—์„œ๊ต์œกํ›„ 3.56±0.32์ ์œผ๋กœ์ƒ์Šนํ•˜์˜€์œผ๋ฉฐํ†ต๊ณ„์ ์œผ๋กœ์œ ์˜ํ•œ์ฐจ์ด๊ฐ€์žˆ์–ด ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ๊ต์œกํ›„์˜๊ฐ„ํ˜ธ์‚ฌ์˜์ˆ˜ํ–‰๋„๊ฐ€์ ์šฉ์ „๋ณด๋‹คํ–ฅ์ƒ๋ ๊ฒƒ์ด๋‹ค ๋Š”๊ฐ€์„ค 2๋Š”์ง€์ง€๋˜์—ˆ๋‹ค (t=-6.72, p<.000)(table 4). ๋ฌธํ•ญ๋ณ„๋กœ๋ถ„์„ํ•œ๊ฒฐ๊ณผ 37๊ฐœ์˜๋ฌธํ•ญ์ค‘ 27๊ฐœ์˜๋ฌธํ•ญ์ด๊ต์œก์ „์—๋น„ํ•ด๊ต์œกํ›„์—์ˆ˜ํ–‰๋„๊ฐ€ํ†ต๊ณ„์ ์œผ๋กœ์œ ์˜ํ•˜๊ฒŒ์ƒ์Šนํ•˜์˜€๋‹ค. ๊ต์œก์ „๊ณผ๋น„๊ตํ•˜์—ฌ๊ต์œกํ›„์—๊ฐ€์žฅ๋งŽ์€์ ์ˆ˜๊ฐ€์ƒ์Šนํ•œ๋ฌธํ•ญ์€ ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋Š”์ฃผ๊ธฐ์ ์œผ๋กœ๊ตํ™˜ํ•˜์ง€์•Š์œผ๋ฉฐ์ž„์ƒ์ ์œผ๋กœ๋ฌธ์ œ๊ฐ€์žˆ๋Š”๊ฒฝ์šฐ์—๋งŒ๊ตํ™˜ํ•œ๋‹ค ์˜€๋‹ค. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์žฌ์‚ฝ์ž…์‹œ๋ชจ๋“ ์ˆ˜์•ก์„ธํŠธ๋„๊ฐ™์ด๊ต์ฒดํ•œ๋‹ค, ๋ถ€์ž‘์šฉ๋ฐœ์ƒ์‹œ์‚ฌ์ •๋„๊ตฌ ( ์ •๋งฅ์—ผ์‚ฌ์ •๋„๊ตฌ, ์นจ์œค / ์ผํ˜ˆ์‚ฌ์ •๋„๊ตฌ ) ๋ฅผ์‚ฌ์šฉํ•œ๋‹ค ๋Š”๋ฌธํ•ญ๋„๊ต์œก์ „์—๋น„ํ•ด๊ต์œกํ›„์—์ ์ˆ˜๊ฐ€ 1์ ์ด์ƒ์ƒ์Šนํ•˜์˜€๋‹ค. 4. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ  2. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—๋Œ€ํ•œ์ง€์‹๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—๋Œ€ํ•œ์ง€์‹์˜์ด์ ์€๊ต์œก์ „ 5.81± 1.06์ , ๊ต์œก์งํ›„ 8.71±1.12์ , ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์—๋Š” 8.31± 0.96์ ์œผ๋กœํ†ต๊ณ„์ ์œผ๋กœ์œ ์˜ํ•˜๊ฒŒ์ƒ์Šน๋˜์–ด ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ๊ต์œกํ›„์˜๊ฐ„ํ˜ธ์‚ฌ์˜์ง€์‹์ˆ˜์ค€์ด๊ต์œก์ „๋ณด๋‹คํ–ฅ์ƒ ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์€ํ”„๋กœํ† ์ฝœ์ ์šฉ์ „ 4์ฃผ๊ฐ„ 9.6% ์—์„œํ”„๋กœํ† ์ฝœ์ ์šฉํ›„ 4์ฃผ๊ฐ„ 17.9% ๋กœ์ธก์ •๋˜์–ด, ํ†ต๊ณ„์ ์œผ๋กœ์œ ์˜ํ•œ์ฐจ์ด๊ฐ€์žˆ์—ˆ์œผ๋‚˜๋ฐœ์ƒ๋ฅ ์ด์ฆ๊ฐ€ํ•˜์—ฌ ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ จ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์ด์ ์šฉ์ „๋ณด๋‹ค๊ฐ์†Œ๋ ๊ฒƒ์ด๋‹ค ๋ผ๋Š”๊ฐ€์„ค 3์€๊ธฐ๊ฐ๋˜์—ˆ๋‹ค (Table 5). Vol. 14 No. 2, 2017 49

์ตœํฌ๊ฐ• ๊ฐ•๋ฏธ์ • ๊ฐ•ํ˜„์ฃผ๋“ฑ Table 3. Knowledge Difference for Management of Peripheral Intravenous Catheter (N=60) Variables Pre training Post training After application M±SD M±SD M±SD F p Scheffe Do sterile dressing on insertion site 0.58±0.50 a 0.97±0.18 b 0.85±0.36 c 16.96 <.001 a<b, c Do regularly replace dressing 0.30±0.46 a 0.73±0.44 b 0.68±0.47 c 15.99.000 a<b, c Make sure the fixed arm board allows for checking circulation of the fingers and the toes Replace peripheral intravenous catheter every 72~96 hours Immediately remove peripheral intravenous catheter after finding out side effect Replace sets of solely used glucose, amino acid every 48 hours Replace a set every 24 hours in case of more than 12.5% glucose, high concentrated fluid like TPN, lipid-soluble fluid, or blood transfusion set Replace a set together in case of exchange the peripheral intravenous catheter Do flushing using 0.9% saline every shift to keep IV patency Apply a warm pack in case of phlebitis accompanied with acute pain and erythema 0.95±0.21 a 1.00±0.00 b 1.00±0.00 c 3.10.047 a<b, c 0.08±0.27 a 0.92±0.27 b 0.92±0.27 c 178.78 <.001 a<b, c 0.13±0.34 a 0.37±0.48 b 0.36±0.48 c 5.53.005 a<b, c 0.88±0.32 0.86±0.34 0.85±0.36 0.14.868 0.98±0.12 0.98±0.12 1.00±0.00 0.50.607 0.25±0.43 a 0.93±0.25 b 0.8±0.32 c 72.79 <.001 a<b, c 0.80±0.40 a 1.00±0.0 b 0.97±0.18 c 10.57 <.001 a<b, c 0.85±0.57 0.95±0.21 0.80±0.40 1.93.148 Total score 5.81±1.06 a 8.71±1.12 b 8.31±0.96 c 133.73 <.001 a<b, c ๋…ผ์˜ ๋ณธ์—ฐ๊ตฌ๋Š”์–ด๋ฆฐ์ด๋ณ‘์›๊ฐ„ํ˜ธ์‚ฌ๋ฅผ๋Œ€์ƒ์œผ๋กœ 2015๋…„๋ณธ์—ฐ๊ตฌํŒ€์ด๊ฐœ๋ฐœํ•œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์—๋Œ€ํ•œ๊ต์œก์„์‹œํ–‰ํ•œ๋’ค๊ต์œก์ „, ํ›„๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—๋Œ€ํ•œ๊ฐ„ํ˜ธ์‚ฌ์˜์ง€์‹๊ณผ์ˆ˜ํ–‰๋„๋ฅผ๋น„๊ตํ•˜๊ณ ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ ์šฉ์ „, ํ›„์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ จ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์„๋น„๊ตํ•˜์—ฌ๊ทธํšจ๊ณผ๋ฅผ์‚ดํŽด๋ณด๊ณ ์žํ•˜์˜€๋‹ค. ๋ณธ์—ฐ๊ตฌ์—์„œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—๋Œ€ํ•œ์ง€์‹์€์ด์  10์ ์ค‘๊ต์œก์ „ 5.81±1.06์ ์—์„œ๊ต์œก์งํ›„ 8.71±1.12์ , ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„ 8.31±0.96์ ์œผ๋กœํ†ต๊ณ„์ ์œผ๋กœ์œ ์˜ํ•˜๊ฒŒ์ƒ์Šนํ•˜์˜€๋‹ค. ๊ต์œก์งํ›„์—๋น„ํ•ดํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์ง€์‹์ด์ ์ด๋‚ฎ์•„์ง„๊ฒƒ์€ํ†ต๊ณ„์ ์œผ๋กœ์œ ์˜ํ•œ์ฐจ์ด๋Š”์—†์—ˆ์œผ๋‚˜๊ต์œกํ›„ 4์ฃผ๊ฐ€์ง€๋‚œ์‹œ์ ์œผ๋กœ๊ต์œก์˜ํšจ๊ณผ๊ฐ€๊ฐ์†Œ๋œ๊ฒƒ์œผ๋กœ์ƒ๊ฐ๋œ๋‹ค. Jeong 12) ์˜์—ฐ๊ตฌ์—์„œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—๋Œ€ํ•œ์ธ์ง€๋„๊ฐ€๋†’์„์ˆ˜๋ก์ˆ˜ํ–‰๋„๊ฐ€๋†’์€๊ฒƒ์œผ๋กœ๋‚˜ํƒ€๋‚ฌ์œผ๋ฉฐ์ธ์ง€๋„๋ฅผ๋†’์ด๊ธฐ์œ„ํ•ด์„œ๋Š”ํ‘œ์ค€ํ™”๋œ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์ง€์นจ๊ฐœ๋ฐœ๋ฐ์ด์—๋Œ€ํ•œ์ง€์†์ ๊ต์œก์ด์ด๋ฃจ์–ด์ ธ์•ผํ•œ๋‹ค๊ณ ํ•˜์˜€๋‹ค. ์ด์—ํ‘œ์ค€ํ™”๋œ๊ต์œกํ”„๋กœ๊ทธ๋žจ์„๊ฐœ๋ฐœํ•˜์—ฌ์ฃผ๊ธฐ์ ์œผ๋กœ์‹œํ–‰ํ•˜๋Š”๊ฒƒ์ดํ•„์š”ํ•˜๋‹ค. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์—๋Œ€ํ•œ์ง€์‹์ธก์ •์‹œ 10๊ฐœ์˜ํ•ญ๋ชฉ์ค‘ 7๊ฐœ์˜ํ•ญ ๋ชฉ์˜ํ‰๊ท ์ ์ˆ˜๊ฐ€์œ ์˜ํ•˜๊ฒŒ์ฆ๊ฐ€ํ•˜์˜€๋Š”๋ฐ๊ฐ€์žฅํ–ฅ์ƒ์ ์ˆ˜๊ฐ€๋†’์•˜๋˜ํ•ญ๋ชฉ์€ ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋Š” 3~4์ผ๋งˆ๋‹ค์ฃผ๊ธฐ์ ์œผ๋กœ๊ตํ™˜ํ•œ๋‹ค ์˜€๋‹ค. CDC (Centers for Disease Control and prevention) ๋‚˜๋ณ‘์›๊ฐ„ํ˜ธ์‚ฌํšŒ์˜์ •๋งฅ์ฃผ์ž…์š”๋ฒ•์‹ค๋ฌด์ง€์นจ๋“ฑ์—ฌ๋Ÿฌ๊ฐ€์ด๋“œ๋ผ์ธ์—์„œ์•„๋™์˜๊ฒฝ์šฐ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์ฃผ์‚ฌ๋Š”์ฃผ๊ธฐ์ ๊ตํ™˜์ด์•„๋‹ˆ๋ผ์ž„์ƒ์ ์ƒํƒœ๋ฅผ๊ณ ๋ คํ•˜์—ฌ๊ตํ™˜ํ•˜๋„๋ก๊ถŒ๊ณ ํ•˜๊ณ ์žˆ์œผ๋‚˜์‹ค์ œ๋ณธ์—ฐ๊ตฌ๋ฅผ์ง„ํ–‰ํ•œ์–ด๋ฆฐ์ด๋ณ‘์›๋ณ‘๋™์—์„œ๋Š”์„ฑ์ธํ™˜์ž์™€๋งˆ์ฐฌ๊ฐ€์ง€๋กœ 4์ผ๋งˆ๋‹ค์ •๊ธฐ์ ๊ตํ™˜์„ํ•˜๊ณ ์žˆ์—ˆ๋‹ค. ๋”ฐ๋ผ์„œ์ด๋ฌธํ•ญ์ด์ด์ „์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ๋ฐฉ๋ฒ•๊ณผ๊ฐ€์žฅํฐ๋ณ€ํ™”๊ฐ€์žˆ๋Š”๊ฒƒ์œผ๋กœ๊ฐ„ํ˜ธ์‚ฌ๋“ค์—๊ฒŒ๊ต์œก์‹œ์ด์—๋Œ€ํ•œ๋‚ด์šฉ์„๊ฐ•์กฐํ•˜์˜€์œผ๋ฉฐ์ด๋กœ์ธํ•ด์ง€์‹์ ์ˆ˜๊ฐ€ํฌ๊ฒŒํ–ฅ์ƒ๋œ๊ฒƒ์œผ๋กœ์ƒ๊ฐ๋œ๋‹ค. ๋ถ€๋ชฉ (arm board) ์„์ด์šฉํ•œ๊ณ ์ •์‹œํ”ผ๋ถ€์ˆœํ™˜์„ํ™•์ธํ•˜๊ธฐ์œ„ํ•ดํ™˜์ž์˜์†๊ฐ€๋ฝ๊ณผ๋ฐœ๊ฐ€๋ฝ์ด๋ณด์ด๋„๋ก๊ณ ์ •ํ•œ๋‹ค, 12.5% ์ด์ƒ์˜ํฌ๋„๋‹น, TPN (Total Parenteral Nutrition) ๊ณผ๊ฐ™์€๊ณ ๋†๋„์ˆ˜์•ก, ์ง€์šฉ์„ฑ์ œ์žฌ๋‚˜ํ˜ˆ์•ก์ œ์žฌ์˜๊ฒฝ์šฐ์—๋Š”์ˆ˜์•ก์„ธํŠธ๋ฅผ 24์‹œ๊ฐ„๋งˆ๋‹ค๊ตํ™˜ํ•œ๋‹ค ๋Š”๋ฌธํ•ญ์€์‹ ๊ทœ๊ต์œก, ๊ฐ์—ผ๊ด€๋ฆฌ, ์•ˆ์ „๊ต์œก๋“ฑ์„ํ†ตํ•ด๊ฐ„ํ˜ธ์‚ฌ๋“ค์ด์ˆ™์ง€ํ•˜๊ณ ์žˆ๋˜๋‚ด์šฉ์ด๋ฏ€๋กœ๊ต์œก์ „๊ณผ์งํ›„, ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์—์„œ๋ชจ๋‘์ ์ˆ˜๊ฐ€๋†’์•˜๋‹ค. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„์˜๋ถ€์ž‘์šฉ๋ฐœ์ƒ์‹œ์ฆ‰์‹œ IV๋ฅผ์ œ๊ฑฐํ•œ๋‹ค ๋Š”๋ฌธํ•ญ์€๊ต์œก 50 Perspectives in Nursing Science

์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ ์šฉ๋ฐํšจ๊ณผ Table 4. Performance Comparison about Nursing Protocol (N=60) Variables Conduct a training regularly regarding to the principles and the practice of intravenous infusion Provide education to a child and to a guardian with education materials containing of management of intravenous infusing, prevention/finding side effect, and signs/symptom to need to notice Pre training M±SD Post training t p M±SD 2.20±0.86 2.93±0.60-5.40 <.001 2.18±1.09 3.03±0.86-4.71 <.001 Keep the dressing site be visible 3.07±0.71 3.45±0.53-3.34.001 Do sterile dressing on the insertion site 2.87±1.03 3.40±0.88-3.03.003 Replace the dressing immediately under contamination or problems 3.75±0.50 3.77±0.42-0.19.846 Fix the intravenous catheter by using an arm board on bendable site like fingers, hand, arm 3.77±0.50 3.78±0.41-0.19.843 and foot Make sure the fixed arm board allows to observe of the insertion area 3.35±0.73 3.67±0.47-2.80.006 Make sure the fixed arm board allows for checking circulation of the fingers and the toes 3.58±0.53 3.63±0.48-0.53.591 Record the insertion status after dressing 3.40±0.80 3.65±0.54-1.98.049 Do not replace a peripheral intravenous catheter regularly except to finding clinical problems 1.85±0.77 3.73±0.44-16.27 <.001 All sets connected to the peripheral intravenous catheter, such as infusion sets, extension 3.63±0.78 3.63±0.61 0.00 1.00 tubes, 3-ways, shall follow the replacement period cycle Replace sets of solely used glucose, amino acid every 96 hours 2.98±1.30 3.65±0.82-3.34.001 Replace a set every 24hours in case of more than 12.5% glucose, high concentrated fluid like 3.85±0.51 3.93±0.25-1.12.262 TPN, lipid-soluble fluid, or blood transfusion set Replace a set together in case of exchange the peripheral intravenous catheter 2.03±0.88 3.23±0.98-7.04 <.001 Do flushing using 0.9% saline every shift to keep IV patency 3.05±0.89 3.58±0.76-3.51.001 In case of injection of medication which is not compatible with 0.9% saline, flush with 5% 3.48±0.87 3.8±0.40-2.95.004 dextrose and then flush with 0.9% saline as well Observe on the peripheral intravenous catheter site every 2 hours 2.27±0.71 3.0±0.78-5.38 <.001 Observe the peripheral intravenous catheter as well as dressing status 3.42±0.67 3.73±0.44-3.04.003 Observe IV patency 3.47±0.62 3.80±0.40-3.47.001 Observe the status of the peripheral intravenous catheter insertion and skin around it 3.50±0.56 3.77±.42-2.91.004 Observe fluid sets (infusion set and connecting set, etc.) 3.57±0.56 3.75±0.43-1.99.049 Make sure infusion rate 3.78±0.41 3.82±0.39-0.45.651 Touch, look at the insertion site and compare to another part 3.50±0.65 3.83±0.37-3.43.001 Use the assessment tool (infiltration/extravasation assessment tool) 2.37±1.02 3.50±0.62-7.31 <.001 Record all findings at the beginning of the shift and then record it additionally after taking 3.40±0.71 3.68±0.50-2.50.014 place side effect Follow the side effect algorithm 2.87±0.89 3.55±0.59-4.93 <.001 Elevate the phlebitis site 3.28±0.78 3.63±0.52-2.88.005 Apply a cold pack on it in case of phlebitis accompanied with acute pain and erythema 3.33±0.75 3.48±0.72-1.11.268 Apply a warm pack(a warm towel) on it in case of phlebitis accompanied with edema 2.45±1.11 3.05±0.93-3.16.002 Stop infusing immediately when you find infiltration/extravasation 3.87±0.34 3.76±0.63 1.16.247 Inform to a doctor infiltration/extravasation, and provide clinical interventions if necessary 3.50±0.74 3.66±0.63-1.21.228 Aspirate the drug inside tissue if necessary 2.70±1.15 3.21±0.95-2.59.011 Remove the peripheral intravenous catheter except of injection an antidote 3.02±0.91 3.4±0.75-2.58.011 Elevate the infiltration/extravasation site 3.20±0.89 3.50±0.70-2.01.047 Apply a warm pack or a cold pack on the infiltration/extravasation site as depending a drug 3.18±0.87 3.52±0.59-2.41.017 Record all observations and interventions when finding side effect 3.45±0.67 3.57±0.56-1.03.302 Do not use a sharp things like scissors when removing a peripheral intravenous catheter 3.35±0.70 3.62±0.58-2.25.026 Total score 3.14±0.35 3.56±0.32-6.72 <.001 Vol. 14 No. 2, 2017 51

์ตœํฌ๊ฐ• ๊ฐ•๋ฏธ์ • ๊ฐ•ํ˜„์ฃผ๋“ฑ Table 5. Incidence Rate of Side Effect Variables Before application After application x 2 p Side effect cases 113 178 Peripheral intravenous catheter insertion cases 1,174 997 30.74 <.001 Incidence rate of side effect (%)* 9.6 17.9 *Side effect cases/peripheral intravenous catheter insertion cases 100. ์ „๊ณผ์งํ›„, ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์—๋ชจ๋‘์ ์ˆ˜๊ฐ€๋‚ฎ์•˜๋‹ค. ๊ต์œก์งํ›„์™€ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์—๋„์˜ค๋‹ต๋ฅ ์ด๋†’์•˜๋˜๋ฌธํ•ญ์œผ๋กœ๋ถ€์ž‘์šฉ์‹œ๋Œ€์ฒ˜์•Œ๊ณ ๋ฆฌ์ฆ˜์—์„œ๋Š”์ •๋งฅ์—ผ์‚ฌ์ •์‹œ VIP (Visual Infusion Phlebitis) score 2์ ์ด์ƒ, ์นจ์œค / ์ผํ˜ˆ 2๋‹จ๊ณ„์ด์ƒ์ธ๊ฒฝ์šฐ์—๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ์ œ๊ฑฐํ•˜๋„๋ก๊ถŒ๊ณ ํ•˜์˜€์œผ๋‚˜๋ถ€์ž‘์šฉ๋ชจ๋‹ˆํ„ฐ๋ง๊ธฐ๊ฐ„์—์ž‘์„ฑ๋œ์ •๋งฅ์ฃผ์‚ฌ๊ด€์ฐฐ๊ธฐ๋ก์ง€๋ฅผ๋ถ„์„ํ•ด๋ณด๋ฉด VIP score 1 ์ ์ธ์ •๋งฅ์—ผ 44๊ฑด์ค‘ 2๊ฑด๋งŒ์œ ์ง€, ๊ด€์ฐฐํ•˜์˜€๊ณ  42๊ฑด์—์„œ๋Š”๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ์ œ๊ฑฐํ•˜์˜€๋‹ค. ๋˜ํ•œ์นจ์œค / ์ผํ˜ˆ 1๋‹จ๊ณ„ 59๊ฑด๋ชจ๋‘๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ์ œ๊ฑฐํ•˜์˜€๋‹ค. ์ด๋Š”๋Œ€๋ถ€๋ถ„์˜๊ฐ„ํ˜ธ์‚ฌ๊ฐ€๋ถ€์ž‘์šฉ์ด์˜์‹ฌ๋˜๋Š”๊ฒฝ์šฐํ•ฉ๋ณ‘์ฆ์ด์‹ฌํ•ด์งˆ๊ฒƒ์„์šฐ๋ คํ•˜์—ฌ๋ถ€์ž‘์šฉ์ดˆ๊ธฐ์—๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ์ œ๊ฑฐํ•œ๊ฒƒ์œผ๋กœ๋ณด์ธ๋‹ค. ๋”ฐ๋ผ์„œ์ž„์ƒ์ ์šฉ์ด๊ฐ€๋Šฅํ•˜๋„๋ก๋ถ€์ž‘์šฉ์‹œ๋Œ€์ฒ˜๋ฐฉ๋ฒ•์ค‘๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์ œ๊ฑฐ๋‹จ๊ณ„์—๋Œ€ํ•œ์ถ”ํ›„๋…ผ์˜๊ฐ€ํ•„์š”ํ• ๊ฒƒ์œผ๋กœ์ƒ๊ฐ๋œ๋‹ค. ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ˆ˜ํ–‰๋„์ ์ˆ˜๋Š”๊ต์œก์ „ 3.14±0.35์—์„œ 3.56±0.32๋กœ์œ ์˜ํ•˜๊ฒŒ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ์ด๋Š” Jeong 12) ์˜์—ฐ๊ตฌ๊ฒฐ๊ณผ์—์„œํ‰๊ท ์ˆ˜ํ–‰๋„ 3.29์ ๋ณด๋‹ค์ ์šฉ์ „์ ์ˆ˜๋Š”๋น„์Šทํ•˜์˜€์œผ๋‚˜์ ์šฉํ›„์ ์ˆ˜๋Š”๋†’์€๊ฒƒ์œผ๋กœ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์ด 37๊ฐœํ•ญ๋ชฉ์ค‘์œ ์˜ํ•˜๊ฒŒ์ˆ˜ํ–‰๋„๊ฐ€์ฆ๊ฐ€ํ•œํ•ญ๋ชฉ์€ 27๊ฐœ๋กœ๊ต์œก์ „๊ณผ๋น„๊ตํ•˜์—ฌ๊ต์œกํ›„์—๊ฐ€์žฅ๋งŽ์€์ ์ˆ˜๊ฐ€์ƒ์Šนํ•œ๋ฌธํ•ญ์€ ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋Š”์ฃผ๊ธฐ์ ์œผ๋กœ๊ตํ™˜ํ•˜์ง€์•Š์œผ๋ฉฐ์ž„์ƒ์ ์œผ๋กœ๋ฌธ์ œ๊ฐ€์žˆ๋Š”๊ฒฝ์šฐ์—๋งŒ๊ตํ™˜ํ•œ๋‹ค ์˜€๋‹ค. ๋ณธ๋ฌธํ•ญ์€์ง€์‹์ ์ˆ˜๋„๊ฐ€์žฅ๋งŽ์ดํ–ฅ์ƒ๋˜์—ˆ๋Š”๋ฐ, ์ด๋Š”์ง€๊ธˆ๊นŒ์ง€๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ์ฃผ๊ธฐ์ ์œผ๋กœ๊ตํ™˜ํ•ด์™”๋˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ๋ฐฉ๋ฒ•๊ณผ๋‹ฌ๋ผ์ง„๊ฒƒ์œผ๋กœ๊ต์œก์‹œ๊ฐ•์กฐํ•˜์—ฌ์„ค๋ช…ํ•˜์˜€์œผ๋ฉฐ์ž„์ƒ์ ์ƒํƒœ๋ฅผ๊ณ ๋ คํ•˜์—ฌ๊ตํ™˜ํ•˜๋„๋กํ•œ์ƒˆ๋กœ์šดํ”„๋กœํ† ์ฝœ์„์ ์šฉํ–ˆ๊ธฐ๋•Œ๋ฌธ์ด๋ผ์ƒ๊ฐ๋œ๋‹ค. ๋‹ค์Œ์œผ๋กœ์ˆ˜ํ–‰๋„์ ์ˆ˜๊ฐ€์ƒ์Šนํ•œํ•ญ๋ชฉ์€ ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์žฌ์‚ฝ์ž…์‹œ๋ชจ๋“ ์ˆ˜์•ก์„ธํŠธ๋„๊ฐ™์ด๊ต์ฒดํ•œ๋‹ค, ๋ถ€์ž‘์šฉ๋ฐœ์ƒ์‹œ์‚ฌ์ •๋„๊ตฌ ( ์ •๋งฅ์—ผ์‚ฌ์ •๋„๊ตฌ, ์นจ์œค / ์ผํ˜ˆ์‚ฌ์ •๋„๊ตฌ ) ๋ฅผ์‚ฌ์šฉํ•œ๋‹ค ์ด๋‹ค. ํ–‰์œ„๋ณ€ํ™”๊ฐ€๋งŽ์•˜๋˜ ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์žฌ์‚ฝ์ž…์‹œ๋ชจ๋“ ์ˆ˜์•ก์„ธํŠธ๋„๊ฐ™์ด๊ต์ฒดํ•œ๋‹ค ๋Š”ํ•ญ๋ชฉ์—๋Œ€ํ•ด์„œ๋Š”์ •๋งฅ์ฃผ์‚ฌ๊ต์ฒด์‹œ๋ชจ๋“ ์ˆ˜์•ก์„ธํŠธ๋ฅผํ•จ๊ป˜๊ต์ฒดํ•˜๋Š”๊ฒƒ์ด์–ด๋ ต๋‹ค๋Š”์‚ฌ์šฉ์ž์˜์˜๊ฒฌ์ด์žˆ์—ˆ๋‹ค. ํ”„๋กœํ† ์ฝœ์ ์šฉ์ „์—๋Š”์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„์™€์ง์ ‘์—ฐ๊ฒฐ๋œ๋ผ์ธ๋งŒ๊ต์ฒดํ•˜์˜€์œผ๋‚˜ํ”„๋กœํ† ์ฝœ์ ์šฉ๋™์•ˆ์•ฝ๋ฌผ๊ณผ์—ฐ๊ฒฐ๋œ์ˆ˜์•ก๋ผ์ธ, ์ค‘๊ฐ„์—ฐ๊ฒฐ๋ผ์ธ์„๋ชจ๋‘๊ต์ฒดํ•˜๋„๋กํ•˜์—ฌ์‹œ๊ฐ„์†Œ์š”๋ฐ์—…๋ฌด๋ถ€๋‹ด์ด๊ฐ€ ์ค‘๋˜์—ˆ์œผ๋ฆฌ๋ผ์ƒ๊ฐ๋œ๋‹ค. ์ดํ•ญ๋ชฉ์€ Choi ๋“ฑ 13) ์˜์—ฐ๊ตฌ์—์„œ๋„์ ์šฉ๋ฅ ์ด 80% ๋กœ๋‚ฎ์•˜์œผ๋ฉฐ๋ณ‘์›๊ฐ„ํ˜ธ์‚ฌํšŒ์˜์ •๋งฅ์ฃผ์ž…์š”๋ฒ•๊ฐ€์ด๋“œ๋ผ์ธ์˜๊ถŒ๊ณ ์ˆ˜์ค€์—ญ์‹œ๊ทผ๊ฑฐ์ˆ˜์ค€ III, ๊ถŒ๊ณ ๋“ฑ๊ธ‰ C๋กœ๋‚ฎ์•„์ถ”ํ›„๋…ผ์˜๊ฐ€ํ•„์š”ํ•˜๋ฆฌ๋ผ์ƒ๊ฐ๋œ๋‹ค. ๋ถ€์ž‘์šฉ๋ฐœ์ƒ์‹œ์‚ฌ์ •๋„๊ตฌ ( ์ •๋งฅ์—ผ์‚ฌ์ •๋„๊ตฌ, ์นจ์œค / ์ผํ˜ˆ์‚ฌ์ •๋„๊ตฌ ) ๋ฅผ์‚ฌ์šฉํ•œ๋‹ค ํ•ญ๋ชฉ์€ํ”„๋กœํ† ์ฝœ์—๋Œ€ํ•œ๊ต์œก๊ณผํ•จ๊ป˜ํ”„๋กœํ† ์ฝœ์ ์šฉ์‹œ์ •๋งฅ์—ผ์‚ฌ์ •๋„๊ตฌ์ธ VIP score ์™€์นจ์œค์‚ฌ์ •๋„๊ตฌ์ธ Infiltration/Extravasation staging์„๊ฐ๊ทผ๋ฌดํŒ€์˜ EMR์นดํŠธ์˜†์—์†Œ์ง€ํ•˜๋„๋กํ•˜์—ฌ๊ฐ„ํ˜ธ์‚ฌ๋“ค์ด์‚ฌ์šฉํ•˜๊ธฐ์‰ฝ๋„๋กํ–ˆ๊ธฐ๋•Œ๋ฌธ์ธ๊ฒƒ์œผ๋กœ์ƒ๊ฐ๋œ๋‹ค. ์ •๋งฅ์—ผ์‚ฌ์ •๋„๊ตฌ์™€์นจ์œค์‚ฌ์ •๋„๊ตฌ๋ฅผ์ „์ž์˜๋ฌด๊ธฐ๋ก์œผ๋กœ์‰ฝ๊ฒŒ์ ‘๊ทผํ• ์ˆ˜์žˆ๋„๋กํ•œ๋‹ค๋ฉด์•ž์œผ๋กœ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ์„๊ฐ๊ด€์ ์ธ๊ธฐ์ค€์—์˜๊ฑฐํ•˜์—ฌ์‚ฌ์ •ํ• ์ˆ˜์žˆ์„๊ฒƒ์ด๋‹ค. ํ”„๋กœํ† ์ฝœ์ ์šฉ์ „๊ณผํ›„์—์ˆ˜ํ–‰๋„์ ์ˆ˜๊ฐ€๋†’์€ํ•ญ๋ชฉ์ธ 12.5% ์ด์ƒ์˜ํฌ๋„๋‹น, TPN๊ณผ๊ฐ™์€๊ณ ๋†๋„์ˆ˜์•ก, ์ง€์šฉ์„ฑ์ œ์žฌ๋‚˜ํ˜ˆ์•ก์ œ์žฌ์˜๊ฒฝ์šฐ์—๋Š”์ˆ˜์•ก์„ธํŠธ๋ฅผ 24์‹œ๊ฐ„๋งˆ๋‹ค๊ตํ™˜ํ•œ๋‹ค ๋Š”์ง€์‹์ ์ˆ˜๋„๋†’์•˜์œผ๋ฉฐ, ์ž„์ƒ์—์„œ์ž˜์‹œํ–‰ํ•˜๊ณ ์žˆ๋Š”๊ฒƒ์„๋ณด์ธ๋‹ค. ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์—๋„๋‚ฎ์€์ ์ˆ˜๋ฅผ๋ณด์ธํ•ญ๋ชฉ์€ ์ •๋งฅ์ฃผ์ž…์š”๋ฒ•์˜์›๋ฆฌ์™€์‹ค๋ฌด์—๋Œ€ํ•ด์ฃผ๊ธฐ์ ์œผ๋กœ๊ต์œก์„๋ฐ›๋Š”๋‹ค, ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๋ถ€์œ„๋Š” 2์‹œ๊ฐ„๋งˆ๋‹ค๊ด€์ฐฐํ•œ๋‹ค, ๊ต์œก์ž๋ฃŒ๋ฅผ์ด์šฉํ•˜์—ฌ๋ณดํ˜ธ์ž์™€ํ™˜์•„๊ต์œก์„ํ•œ๋‹ค ์ˆœ์ด์—ˆ์œผ๋ฉฐ์ด๋Š”ํ”„๋กœํ† ์ฝœ์ ์šฉํ›„์—๋„๋ณ€ํ™”๊ฐ€์ž˜์ผ์–ด๋‚˜์ง€์•Š์•˜๋˜ํ•ญ๋ชฉ์ด๋‹ค. ์ž…์‚ฌ์‹œ์‹ ์ž…๊ฐ„ํ˜ธ์‚ฌ์—๊ฒŒ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ๊ต์œก์„์‹ค์‹œํ•˜๊ณ ์žˆ์œผ๋‚˜, ์ฃผ๊ธฐ์ ์ธ๊ฐ„ํ˜ธ์‚ฌ๊ต์œก์ด์—†์–ด ์ •๋งฅ์ฃผ์ž…์š”๋ฒ•์˜์›๋ฆฌ์™€์‹ค๋ฌด์—๋Œ€ํ•ด์ฃผ๊ธฐ์ ์œผ๋กœ๊ต์œก์„๋ฐ›๋Š”๋‹ค ๋Š”ํ•ญ๋ชฉ์ด๊ฐ€์žฅ๋‚ฎ์€์ ์ˆ˜๋ฅผ๋ณด์˜€์„๊ฒƒ์œผ๋กœ์ƒ๊ฐํ•œ๋‹ค. ์ด์—ํ‘œ์ค€ํ™”๋œ๊ต์œกํ”„๋กœ๊ทธ๋žจ์„๊ฐœ๋ฐœํ•˜์—ฌ์ฃผ๊ธฐ์ ์œผ๋กœ์‹œํ–‰ํ•˜๋Š”๊ฒƒ์ดํ•„์š”ํ•˜๋‹ค. ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๋ถ€์œ„๋Š” 2์‹œ๊ฐ„๋งˆ๋‹ค๊ด€์ฐฐํ•œ๋‹ค ํ•ญ๋ชฉ์€ํ”„๋กœํ† ์ฝœ๊ต์œก์‹œ์—๊ฐ•์กฐํ•˜์˜€์œผ๋‚˜์ถ”๊ฐ€์—…๋ฌด๋ถ€๋‹ด์œผ๋กœ์ˆ˜ํ–‰๋„๊ฐ€๋‚ฎ์•˜๋‹ค๊ณ ์ƒ๊ฐ๋œ๋‹ค. ํ”„๋กœํ† ์ฝœ์‚ฌ์šฉ์ž์ค‘ 6๋ช…์ด 2์‹œ๊ฐ„๋งˆ๋‹ค๊ด€์ฐฐํ•˜๋Š”๊ฒƒ์ดํ˜„์‹ค์ ์œผ๋กœ์–ด๋ ต๋‹ค๊ณ ๊ธฐ์ˆ ํ•˜์˜€๋‹ค. ์•„๋™์€์„ฑ์ธ์—๋น„ํ•˜์—ฌํ”ผํ•˜์ธต์ด๋‘๊ป๊ณ ํ˜ˆ๊ด€์ด์•ฝํ•˜์—ฌ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๊ณผ์œ ์ง€๊ฐ€์–ด๋ ต๊ณ  3) ๋ฏธ์„ธํ•œ์ฒ˜์น˜๊ฐ€๋งŽ๊ณ ํ˜‘์กฐ๊ฐ€๋˜์ง€์•Š์•„์„ฑ์ธ์—๋น„ํ•ด๊ฐ„ํ˜ธ์ฒ˜์น˜์‹œ๊ฐ„์ด๋งŽ์ด์†Œ์š”๋˜๋Š”๊ฒƒ์ด์‚ฌ์‹ค์ด๋‹ค. ๊ทธ๋Ÿฌ๋‚˜์‚ฝ์ž…๋ถ€์œ„๋ฅผ์ž์ฃผ๊ด€์ฐฐํ•˜๋Š”๊ฒƒ์€๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—์žˆ์–ด๋งค์šฐ์ค‘์š”ํ•œ๋ถ€๋ถ„์ด๋ฉฐ 52 Perspectives in Nursing Science

์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ ์šฉ๋ฐํšจ๊ณผ Gorski ๋“ฑ 14) ์˜์—ฐ๊ตฌ์—๋”ฐ๋ฅด๋ฉด์•„๋™์˜๊ฒฝ์šฐ์ตœ์†Œํ•œ 1์‹œ๊ฐ„๋งˆ๋‹ค๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๋ถ€์œ„๋ฅผ๊ด€์ฐฐํ•˜๋ผ๊ณ ๊ถŒ๊ณ ํ•˜๊ณ ์žˆ๋‹ค. ์•„๋™์˜์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ จ๋ถ€์ž‘์šฉ์„์กฐ๊ธฐ์—๋ฐœ๊ฒฌํ•˜๊ณ ๋Œ€์ฒ˜ํ•˜๊ธฐ์œ„ํ•ด๋ฐ˜๋ณต์ ์ธ๊ต์œก์œผ๋กœ์žฆ์€๊ด€์ฐฐ์˜ํ•„์š”์„ฑ์„๊ฐ•์กฐํ•ด์•ผํ• ๊ฒƒ์ด๋‹ค. ๋ณดํ˜ธ์ž๊ต์œก์„์œ„ํ•œ๋ณดํ˜ธ์ž์šฉ๊ต์œก์ž๋ฃŒ๋ฅผ๋ฐฐ๋ถ€ํ•˜์˜€์œผ๋‚˜ ๊ต์œก์ž๋ฃŒ๋ฅผ์ด์šฉํ•˜์—ฌ๋ณดํ˜ธ์ž์™€ํ™˜์•„๊ต์œก์„ํ•œ๋‹ค ๋Š”ํ•ญ๋ชฉ์˜์ˆ˜ํ–‰๋„๊ฐ€๋‚ฎ๊ฒŒ๋‚˜ํƒ€๋‚ฌ๋‹ค. ๋ณดํ˜ธ์ž๋ฅผ๋Œ€์ƒ์œผ๋กœํ•˜๋Š”๊ต์œก์€์•„๋™์˜์ด์ƒ๋ฐ˜์‘์—๋Œ€ํ•œ๋ณดํ˜ธ์ž์˜๋ฏผ๊ฐ์„ฑ๊ณผ๋Œ€์ฒ˜๋Šฅ๋ ฅ์„๋†’์ผ์ˆ˜์žˆ์–ด์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์—๋งค์šฐ์ค‘์š”ํ•˜๋‹ค. ๋”ฐ๋ผ์„œ๊ฐ„ํ˜ธ์‚ฌ๋“ค์—๊ฒŒ๋ณดํ˜ธ์ž๊ต์œก์—๋Œ€ํ•œ์ค‘์š”์„ฑ์„๊ฐ•์กฐํ•˜๋Š”๊ฒƒ์ดํ•„์š”ํ•˜๋‹ค. ๋˜ํ•œ๋ณดํ˜ธ์ž์šฉ๊ต์œก์ž๋ฃŒ๋ฅผ์‰ฝ๊ฒŒ์‚ฌ์šฉํ• ์ˆ˜์žˆ๋„๋ก์ „์ž์˜๋ฌด๊ธฐ๋ก๋‚ด๊ต์œก์ž๋ฃŒ๋‚˜๋ณดํ˜ธ์ž์šฉ์„ค๋ช…์ฒ˜๋ฐฉ์„๊ฐœ๋ฐœํ•˜์—ฌํ™œ์šฉํ•˜๋Š”๊ฒƒ์ด๋„์›€์ด๋ ๊ฒƒ์ด๋‹ค. ๋ณธ์—ฐ๊ตฌ์—์„œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์„์กฐ์‚ฌํ•œ๊ฒฐ๊ณผํ”„๋กœํ† ์ฝœ์ ์šฉ์ „์€ 9.6%, ์ ์šฉํ›„ 17.9% ๋กœ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์ด์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ์ด๋Š”ํ”„๋กœํ† ์ฝœ์—๋”ฐ๋ผ๋ถ€์ž‘์šฉ์„์ •๋งฅ์—ผ๊ณผ, ์นจ์œค, ์ผํ˜ˆ๋กœํ•œ์ •์ง€์—ˆ๋Š”๋ฐํ”„๋กœํ† ์ฝœ์ ์šฉ์ „์—๋Š”์ด์—๋Œ€ํ•œ๊ต์œก์ด์‹œํ–‰๋˜๊ธฐ์ „์œผ๋กœ๋ถ€์ž‘์šฉ์—๋Œ€ํ•œ์ •ํ™•ํ•œ์ดํ•ด๋ฐ์‚ฌ์ •์ด์ด๋ฃจ์–ด์ง€์ง€์•Š์•˜์„๊ฒƒ์œผ๋กœ์ƒ๊ฐ๋œ๋‹ค. ํ•œํŽธ๊ธฐ์กด์˜์—ฐ๊ตฌ๊ฒฐ๊ณผ๋ฅผ์‚ดํŽด๋ณด๋ฉด์ •๋งฅ์ฃผ์‚ฌ๊ด€์ฐฐ๊ธฐ๋ก์ง€๋กœ์•„๋™์˜์ •๋งฅ์ฃผ์‚ฌ์นจ์œค๋ฐœ์ƒ์œ„ํ—˜์š”์ธ์„๋ถ„์„ํ•œ Sung ๋“ฑ 8) ์˜์—ฐ๊ตฌ์—์„œ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ จ์นจ์œค๋ฐœ์ƒ๋ฅ ์€ 23.7% ์ด๋ผ๊ณ ๋ณด๊ณ ํ•˜์˜€์œผ๋ฉฐ Choi ๋“ฑ 13) ์˜์—ฐ๊ตฌ์—์„œ์˜๋ฌด๊ธฐ๋ก๋ถ„์„์„ํ†ตํ•ด๋ถ„์„ํ•œ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์€ 17% ์˜€๋‹ค. Choi ๋“ฑ 13) ์˜์—ฐ๊ตฌ์—์„œ๊ธฐ์กด์—ฐ๊ตฌ์—๋น„ํ•ด๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์ด๋‚ฎ์€๊ฒƒ์€์˜๋ฌด๊ธฐ๋ก๋ถ„์„์„ํ†ตํ•œ๊ฒƒ์œผ๋กœ๊ธฐ๋ก์˜๋ˆ„๋ฝ์˜์˜ํ–ฅ์„๋ฐฐ์žฌํ• ์ˆ˜์—†๋‹ค๊ณ ํ•˜์˜€๋‹ค. ํ”„๋กœํ† ์ฝœ์ ์šฉ์ „์˜๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ๋ณด๋‹ค์‚ฌํ›„์˜๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์ด์ฆ๊ฐ€ํ•œ๊ฒƒ์€๊ฐ๊ด€์ ์ธ์‚ฌ์ •๋„๊ตฌ๋ฅผ์ด์šฉํ•˜์—ฌ์ž์ฃผ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„๋ฅผ์ •ํ™•ํžˆ์‚ฌ์ •ํ•˜์—ฌ๋ถ€์ž‘์šฉ 1๋‹จ๊ณ„์—์„œ๋ถ€ํ„ฐ๋ถ€์ž‘์šฉ์œผ๋กœ์ธ์ง€ํ•˜๊ณ ๊ธฐ๋กํ•˜๊ฒŒ๋œ๊ฒฐ๊ณผ๋ผ๊ณ ์ƒ๊ฐ๋œ๋‹ค. ๋˜ํ•œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ์ฃผ๊ธฐ์ ์œผ๋กœ๊ตํ™˜ํ•˜์ง€์•Š๊ณ ์ž„์ƒ์ ์œผ๋กœ๋ฌธ์ œ๊ฐ€์žˆ๋Š”๊ฒฝ์šฐ์—๋งŒ๊ตํ™˜ํ•˜๋„๋กํ•˜์—ฌ์ „์ฒด๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๊ฑด์ˆ˜์˜๊ฐ์†Œ์˜์˜ํ–ฅ์œผ๋กœ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์ด์ฆ๊ฐ€๋œ๊ฒƒ์œผ๋กœ๋‚˜ํƒ€๋‚ฌ๋‹ค๊ณ ์ƒ๊ฐ๋œ๋‹ค. ์‹ค์ œ๊ฐ„ํ˜ธ์‚ฌ๋“ค์ดํ”„๋กœํ† ์ฝœ์ ์šฉํ›„๋Š๋‚€์ ์—์„œ์—ฐ๊ตฌ๋ฅผํ†ตํ•ด๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„๋ฅผ๋”์ž์ฃผ์ฃผ์˜๊นŠ๊ฒŒ์ž์ฃผํ™•์ธํ• ์ˆ˜์žˆ์—ˆ๋‹ค๋Š”๋‹ต๋ณ€์ด๋‹ค์ˆ˜์žˆ์—ˆ์œผ๋ฉฐ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ถ€์œ„์˜์„ธ์‹ฌํ•œ๊ด€์ฐฐ๋กœ๋ถ€์ž‘์šฉ์‹œ์ฆ‰์‹œ์ค‘์žฌํ• ์ˆ˜์žˆ์—ˆ๋‹ค๋Š”์˜๊ฒฌ์œผ๋กœ๋ณด์•„์ •ํ™•ํ•œ์‚ฌ์ •๊ณผ์ฃผ์˜๊นŠ์€๊ด€์ฐฐ๋กœํ”„๋กœํ† ์ฝœ์ ์šฉ์ „๋ณด๋‹ค์กฐ๊ธฐ์—๋ถ€์ž‘์šฉ์„๋ฐœ๊ฒฌํ•˜๊ณ ๋Œ€์ฒ˜ํ•˜์˜€๊ธฐ๋•Œ๋ฌธ์ผ๊ฒƒ์ด๋‹ค. ์•„๋™์€ํ˜ˆ๊ด€์€๊ฐ€๋Š˜๊ณ ์—ฐ์•ฝํ•˜๊ธฐ๋•Œ๋ฌธ์—์ •๋งฅ์ฃผ์‚ฌ๋ฅผ์‚ฝ์ž…ํ•˜๊ธฐ์–ด๋ ต๊ณ ์ฒœ์ž๋™์•ˆ๊ฐ€๋งŒํžˆ์žˆ์ง€์•Š๊ณ ๊ณ„์†์›€์ง์ด๋ฏ€๋กœํ˜ˆ๊ด€๋ฒฝ ์˜์†์ƒ์€๋”์šฑ์ฆ๊ฐ€ํ•˜๊ฒŒ๋˜๋ฉฐ์นดํ…Œํ„ฐ๋์ด์—ฐ์•ฝํ•œํ˜ˆ๊ด€๋ฒฝ์—๊ตฌ๋ฉ์„๋‚ด์–ดํ˜ˆ๊ด€๋ฒฝ์ด๊ธฐ๊ณ„์ ์†์ƒ์„์ž…๊ฒŒ๋˜๋ฉด์ˆ˜์•ก์ด์ฃผ์œ„์กฐ์ง์œผ๋กœ์Šค๋ฉฐ๋“ค์–ด๊ฐ€๋ฏ€๋กœ์นจ์œค์ด๋ฐœ์ƒํ•˜๊ฒŒ๋œ๋‹ค. 7) ์˜์œ ์•„๋Š”์œ ์—ฐํ•œํ”ผํ•˜์กฐ์ง์„๊ฐ€์ง€๊ณ ์žˆ๊ธฐ๋•Œ๋ฌธ์—์„ฑ์ธ์—๋น„ํ•ด๋”์šฑ๋”์นจ์œค์—์ทจ์•ฝํ•˜๊ฒŒ๋œ๋‹ค. 15) ๋˜ํ•œ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ€์ง€์—ฐ๋˜๊ฑฐ๋‚˜์‹คํŒจํ•˜๋ฉด์ •๋งฅ์„ํ†ตํ•œ์น˜๋ฃŒ๊ฐ€์ง€์—ฐ๋˜์–ด๋ฐœ์ƒํ•˜๋Š”ํ•ฉ๋ณ‘์ฆ์ด์ฆ๊ฐ€ํ• ๋ฟ๋งŒ์•„๋‹ˆ๋ผํ™˜์•„๋Š”ํ†ต์ฆ๊ณผ๋ถˆ์•ˆ์„๊ฒฝํ—˜ํ•˜๊ณ ๋ถ€๋ชจ์˜๋งŒ์กฑ๋„๋Š”๊ฐ์†Œํ•œ๋‹ค๊ณ ํ•˜์˜€๋‹ค. 16) ๋”ฐ๋ผ์„œ์•„๋™๊ฐ„ํ˜ธ์ค‘์นจ์Šต์ ์ฒ˜์น˜์ธ๋ง์ดˆ์ •๋งฅ์‚ฝ์ž…์„์ค„์ด๋Š”๊ฒƒ์ด๋ฌด์—‡๋ณด๋‹ค๋„์ค‘์š”ํ•˜๋‹ค. ๋ณธ์—ฐ๊ตฌ์—์„œ๋Š”๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์‚ฝ์ž…๊ฑด์ˆ˜๋Š”ํ”„๋กœํ† ์ฝœ์ ์šฉ์ „ 4์ฃผ๊ฐ„ 1,174 ๊ฑด, ์ ์šฉํ›„ 4์ฃผ๊ฐ„ 997๊ฑด์œผ๋กœ์‚ฝ์ž…๊ฑด์ˆ˜๋ฅผ๊ฐ™์€๊ธฐ๊ฐ„์žฌ์›ํ™˜์ž์ˆ˜๋กœ๋‚˜๋ˆ„์–ด์‚ฝ์ž…๋ฅ ์„๊ณ„์‚ฐํ•œ๊ฒฐ๊ณผ 33.5% ์—์„œ 26.5% ๋กœ์œ ์˜ํ•˜๊ฒŒ๊ฐ์†Œํ•˜์˜€๋‹ค. ์ด๋Š”๊ธฐ์กด์—๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๋ฅผ 4์ผ๋งˆ๋‹ค๊ตํ™˜ํ•˜๋˜๊ฒƒ์„์ž„์ƒ์ ์œผ๋กœ๋ฌธ์ œ๊ฐ€์žˆ๋Š”๊ฒฝ์šฐ์—๋งŒ๊ตํ™˜ํ•˜๋„๋กํ•˜์—ฌ๊ฐ์†Œํ•œ๊ฒƒ์œผ๋กœ์ƒ๊ฐ๋œ๋‹ค. ์‹ค์ œ๊ฐ„ํ˜ธ์‚ฌ๋“ค์ดํ”„๋กœํ† ์ฝœ์‚ฌ์šฉํ›„๋Š๋‚€์ ์ค‘์ข‹์•˜๋˜์ ์— ๋ฌธ์ œ๊ฐ€์—†์„์‹œ์žฌ์‚ฝ์ž…์„ํ•˜์ง€์•Š์•„ํ™˜์•„์—๊ฒŒ๊ณ ํ†ต์„์ฃผ์ง€์•Š์•˜๋‹ค ์™€ ์ฃผ๊ธฐ์ ๊ตํ™˜๋‚ ์งœ๋ฅผ์‹ ๊ฒฝ์“ฐ์ง€์•Š์•„๋„๋˜์–ด์—…๋ฌด๋ถ€๋‹ด์ด๊ฐ์†Œํ–ˆ๋‹ค, ์ž์ฃผ๊ต์ฒดํ•˜์ง€์•Š์•„๋ณดํ˜ธ์ž๋งŒ์กฑ๋„๊ฐ€๋†’์•„์ง ์œผ๋กœ๊ธฐ์ˆ ํ•˜์˜€๋‹ค. ์ด๋Š”์ฃผ๊ธฐ์ ๊ตํ™˜์„ํ•˜์ง€์•Š๋Š”์ƒˆ๋กœ์šดํ”„๋กœํ† ์ฝœ์ ์šฉ์œผ๋กœํ™˜์ž๋“ค์—๊ฒŒ๋ถˆํ•„์š”ํ•œ์นจ์Šต์ ์ฒ˜์น˜๋ฅผ์ค„์ผ์ˆ˜์žˆ์—ˆ์œผ๋ฉฐ๊ฐ„ํ˜ธ์‚ฌ์—…๋ฌด์—์žˆ์–ด์„œ๋„๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ์˜์ •๊ธฐ์ ๊ตํ™˜์—๋Œ€ํ•œ์—…๋ฌด๋ถ€๋‹ด์„๊ฐ์†Œ์‹œํ‚ค๋Š”ํšจ๊ณผ๊ฐ€์žˆ์—ˆ๋‹ค๊ณ ์ƒ๊ฐ๋œ๋‹ค. ํ•œํŽธ, ๋ณธ์—ฐ๊ตฌ์—์„œ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ๊ต์œก์„๋ฐ›์€๊ฐ„ํ˜ธ์‚ฌ๋“ค์ด์ •๋งฅ์ฃผ์‚ฌ๋ถ€์ž‘์šฉ์„๊ด€์ฐฐํ•˜๊ณ ์ค‘์žฌ๋ฅผํ•˜๋Š”๊ณผ์ •์—์„œ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์„๊ฐ™์ด์ธก์ •ํ•จ์œผ๋กœ์จ๊ฐ๊ด€์ ์ธ์ž๋ฃŒ์ˆ˜์ง‘์ด๋˜์ง€์•Š์€๋ถ€๋ถ„์€์ œํ•œ์ ์ด๋ผํ• ์ˆ˜์žˆ๋‹ค. ๊ฒฐ๋ก  ๋ณธ์—ฐ๊ตฌ๋Š”์„œ์šธ์‹œ์†Œ์žฌ์ƒ๊ธ‰์ข…ํ•ฉ๋ณ‘์›์˜์–ด๋ฆฐ์ด๋ณ‘์› 4๊ฐœ๋ณ‘๋™์—์„œ๊ทผ๋ฌดํ•˜๊ณ ์žˆ๋Š”๊ฐ„ํ˜ธ์‚ฌ๋ฅผ๋Œ€์ƒ์œผ๋กœ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ๊ต์œก์„์‹œํ–‰ํ•˜๊ณ ๊ต์œก๋ฐ›์€๊ฐ„ํ˜ธ์‚ฌ๋“ค์ด์ด๋ฅผ์—…๋ฌด์—์ ์šฉํ•˜๋„๋กํ•˜์—ฌ๊ต์œก์ „, ํ›„์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธ์—๋Œ€ํ•œ์ง€์‹๊ณผ์ˆ˜ํ–‰๋„๋ฐํ”„๋กœํ† ์ฝœ์ ์šฉ์ „, ํ›„์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ จ๋ถ€์ž‘์šฉ๋ฐœ์ƒ๋ฅ ์„๋น„๊ตํ•˜์—ฌ๊ทธํšจ๊ณผ๋ฅผํ™•์ธํ•˜๋Š”๋‹จ์ผ๊ตฐ์‹œ๊ณ„์—ด์„ค๊ณ„์˜์ „ํ›„๋น„๊ต์—์˜ํ•œ์œ ์‚ฌ์‹คํ—˜์—ฐ๊ตฌ์ด๋‹ค. ์—ฐ๊ตฌ๊ฒฐ๊ณผ์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ๊ต์œก์ด๊ฐ„ํ˜ธ์‚ฌ๋“ค์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ จ์ง€์‹์„ํ–ฅ์ƒ์‹œํ‚ฌ๋ฟ๋งŒ์•„๋‹ˆ๋ผ์—…๋ฌด์ˆ˜ํ–‰๋„๋„๋†’์ž„์„์•Œ์ˆ˜์žˆ์—ˆ๋‹ค. ์ด์—๋ณธ๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ฐ„ํ˜ธํ”„๋กœํ† ์ฝœ์ด์ž„์ƒ์—์„œ๊ทผ๋ฌดํ•˜๋Š”๊ฐ„ํ˜ธ์‚ฌ๋“ค์ด๋ณด๋‹ค๊ณผํ•™์ ์ธ๊ทผ๊ฑฐ๋ฅผ๊ฐ€์ง€๊ณ ๊ฐ„ํ˜ธ์—… Vol. 14 No. 2, 2017 53

์ตœํฌ๊ฐ• ๊ฐ•๋ฏธ์ • ๊ฐ•ํ˜„์ฃผ๋“ฑ ๋ฌด๋ฅผํ• ์ˆ˜์žˆ์œผ๋ฉฐ๋˜ํ•œ๊ฐ„ํ˜ธ์—…๋ฌด์˜ํšจ์œจ์„ฑ์ด๊ฐœ์„ ๋˜๋Š”๋ฐ๊ธฐ์—ฌํ• ๊ฒƒ์œผ๋กœ์ƒ๊ฐ๋œ๋‹ค. ๋ณธ์—ฐ๊ตฌ๊ฒฐ๊ณผ๋ฅผ๋ฐ”ํƒ•์œผ๋กœ์•„๋ž˜์™€๊ฐ™์ด์ œ์–ธํ•˜๊ณ ์žํ•œ๋‹ค. ์ฒซ์งธ, ํ–ฅํ›„๋Œ€์ƒ๋ณ‘๋™์„์–ด๋ฆฐ์ด๋ณ‘์›์ „์ฒด๋กœํ™•๋Œ€ํ•˜์—ฌ๋ณธํ”„๋กœํ† ์ฝœ์˜ํšจ๊ณผ๋ฅผ๊ฒ€์ฆํ•˜๋Š”์—ฐ๊ตฌ๋ฅผ์ œ์–ธํ•œ๋‹ค. ๋‘˜์งธ, ํƒ€๋ณ‘์›์—์„œ๋„์•„๋™์˜๋ง์ดˆ์ •๋งฅ์ฃผ์‚ฌ๊ด€๋ฆฌ์‹œ๋ณธํ”„๋กœํ† ์ฝœ์„์ ์šฉํ•ด๋ณผ๊ฒƒ์„์ œ์–ธํ•œ๋‹ค. REFERENCES 1. Kim EJ, Kim HJ, Kim HJ, Kim KH, Kim SH, Lee SC, et al. Retrospective analysis for complications of the central venous catheter in patients with cancer at a single center in Korea. Korean J Hosp Palliat Care. 2010;13(1):24-31. 2. Lee GS. Factors related to the duration of PIV in hospitalized children [dissertation]. Seoul: Yonsei University; 2005. 3. Oh HS, Jeong IS, Ahn SH, Choe KW. A study on the characteristics of the intravenous therapy for children in the hospital. Korean J Nosocominal Infect Control. 1997;2(1):29-39. 4. Kim HJ. Factors related to the restart of PIV in hospitalized children - data from patients cared by the IV team nurses [dissertation]. Seoul: Yonsei University; 2006. 5. Rosenthal K. Infiltration: an ounce of prevention. Nurs Made Incred Easy. 2003;1(2):60-2. 6. Garland JS, Dunne WM, Havens P, Hintermeyer M, Bozzette MA, Wincek J, et al. Peripheral intravenous catheter complication in critically ill children: a prospective study. Pediatrics. 1992;89(6):1145-50. 7. Amjad I, Murphy T, Nylander-Housholder L, Ranft A. A new approach to management of intravenous infiltration in pediatric patients: pathophysiology, classification, and treatment. J Infus Nurs. 2011;34(4):242-9. https://doi.org/10.1097/nan.0b013e31821da1b3 8. Sung SH, Kim HS. Risk factors of intravenous infiltration in children. J Korean Clin Nurs Res. 2007;13(2):61-72. 9. Gu MO, Cho YA, Cho MS, Eun Y, Jeong JS, Jung IS, et al. Adaptation of intravenous infusion nursing practice guideline. J Korean Clin Nurs Res. 2013;19(1):128-42. https://doi.org/10.22650/jkcnr.2013.19.1.128 10. Han SS, Park SK. The evaluation of medical quality improvement activities through standardised intravenous injection control instruction. J East West Nurs Res. 2005;11(2):137-45. 11. Cohen J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Earlbaum Associates. 12. Jeong MR. Perception and performance on the prevention management of peripheral intravenous therapy complications [dissertation]. Suwon: Ajou University; 2010. 13. Choi HG, Kang MJ, Kang HJ, Kim EH, Bang KS. Development of an evidence-based nursing protocol for management of peripheral catheters in children. J Korean Clin Nurs Res. 2016;22 (1):56-67. https://doi.org/10.22650/jkcnr.2016.22.1.56 14. Gorski LA, Hallock D, Kuehn SC, Morris P, Russell JM, Skala LC. Recommendations for frequency of assessment of the short peripheral catheter site. J Infus Nurs. 2012;35(5):290-2. https://doi.org/10.1097/nan.0b013e318267f636 15. McCullen KL, Pieper B. A retrospective chart review of risk factors for extravasation among neonates receiving peripheral intravascular fluids. J Wound Ostomy Continence Nurs. 2006; 33(2):133-9. 16. Peterson KA, Phillips AL, Truemper E, Agrawal S. Does the use of an assistive device by nurses impact peripheral intravenous catheter insertion success in Children. J Pediatr Nurs. 2012;27(2):134-43. https://doi.org/10.1016/j.pedn.2010.10.009 54 Perspectives in Nursing Science